













Anne Therese Stevens 
B.Sc (Honours) University of Cape Town 
Supervisors : Prof. M.R. Caira 
Prof. R. Hunter 
Thesis presented for the degree of 
MASTER OF SCIENCE 
in the 
Department of Chemistry 
UNIVERSITY OF CAPE TOWN 










The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 












The acetonide derivative of (rac)-albuterol has been prepared and used as a substrate in co-
crystallisation experiments with several acidic resolving agents~ Successful resolution of the 
acetonide was achieved with both di-0-benzoyl- and di-0-toluoyltartaric acid, with the (2S,3S)-
enantiomer of the acid selectively co-crystallising with the desired (R)-albuterol acetonide. High 
performance liquid chromatography on a chiral stationary phase, and 1H NMR experiments 
using a chiral shift reagent were used to assess the optical purity of the resolved material. Acid 
hydrolysis of the resolved acetonide gave rise to the target, (R)-albuterol, which was isolated as 
an acetate salt. The inferred absolute configuration of the resolved acetonide was assessed by 1H 
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CHAPTER 1 INTRODUCTION 
1.1 Chiral Drugs 
1.1.1 Background 
The enantiomers of a racemate frequently show different behaviour within biological systems, 1 
and as early as 1904 Cushner showed that the effect of (-)-hyoscyamine 1 on pupil nerve 
endings was approximately double that of its racemate. The importance of chiral compounds 
was brought to the attention of the pharmaceutical industry and the general public in the early 
1960's with the sedative thalidomide 2. Marketed as a racemate, the drug caused foetal limb 
abnormalities and this teratogenic activity has been reported to reside in the (S)-enantiomer,3 
although this finding remains controversial.4 
2 
Numerous single enantiomer drugs have since been developed and the first wave of these are 
about to lose their 20 year patent protection.5 By 1994, 20% of the world's 95 top selling drugs 
were single enantiomers4 and it is estimated that 80% of drugs currently in the development 
phase fall into this category.6 The sales of single isomer pharmaceuticals has grown at 
approximately 20% per annum for the last 5 years to reach $73 billion • in 1996.5 Much of the 
impetus for this movement lies with the regulatory requirements of the US Food and Drug 
Administration (FDA). In 1987 the agency issued a set of initial guidelines for the manufacture 
of drug substances7 which was appended with the ·'Policy Statement on the Development of 
New Stereoisomeric Drugs" in 1992.8 The key concept of this statement is given in the General 
Policy section : 
The stereoisomeric composition of a drug with a chiral centre should be known, and the 
quantitative isomeric composition of the material used in pharmacologic, toxicologic and 
clinical studies known. Specifications for a final product should assure identity, strength, 
quality, and purity from a stereochemical viewpoint. 
• I billion = 109 
2 
In addition to the development of new molecules, there has also been much interest in the 
redevelopment of drugs whose active ingredient is the single enantiomer of a previously 
approved racemate. Although there is pessimism about the initial promise held in these racemic 
switches,5 an incentive announced by the FDA recently9 extends the marketing exclusivity of 
these drugs to five years. It is into this category that the drug under investigation in this work, 
albuterol (or salbutamol) 3, falls. 
HO 
1.1.2 Producing Single Enantiomers 
Driven by these trends in the pharmaceutical industry, enantioselective production and analytical 
technology have become extremely active areas of research. There are 3 broad approaches to 
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Fig 1.1: Approaches to the manufacture of single isomers 
The chiral pool methods utilise abundantly available chiral starting materials of high optical 
purity which are transformed into the drug while maintaining the integrity of the desired chiral 
centres. The starting material may have its source in nature, e.g. (S)-proline used in the synthesis 
of the neuroleptic remoxipride (Scheme 1.1 ), 14 or in de novo fermentation processes whereby 
carbohydrate feedstocks are converted to both simple molecules, e.g. L-amino acids, and more 
complex antibiotics, vitamins and hormones. Enantiopure products that are now routinely 
synthesised on a large scale can also be regarded as part of the chiral pool. This is exemplified 
by (R)-phenylglycine which is contained as a side chain in several P-lactam antibiotics. 
3 
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Scheme 1.1: The synthesis of remoxipride from (S)-proline 
In asymmetric synthesis, a prochiral starting material is stereoselectively converted into a chiral 
product An enantiomerically pure reagent may be used in stoichiometric or catalytic amounts to 
induce the required chirality. This can be illustrated by two routes developed for the synthesis of 
the analgesic, (S)-naproxen. In the former case, (2R,3R)-tartaric acid is used as a chiral auxiliary 
in a synthesis called the Zambon process15 (Scheme 1.2). Alternatively, hydrogenation using a 






Scheme 1.2: The Zambon process for (S)-naproxen 





Scheme 1.3: Synthesis of (S)-naproxen using asymmetric hydrogenation 
OH 
OH 
Although the majority of enzymatic transformations currently in use are kinetic resolutions, a 
number of truly asymmetric transformations are available and this pool of reactions is constantly 
increasing. An attractive route to enantiopure P-amino alcohols, of which albuterol is one, is via 
optically active cyanohydrins and this has recently been achieved for the bronchodilator (R)-
terbutaline 17 (Scheme 1.4 ). 
4 









OH OH OH (R)-terbutaline 
Scheme 1.4: Biocatalytic route to (R)-terbutaline 
The catalysis of kinetic resolutions may once again be chemical or biological. Diltiazem, a drug 
included in the chiral top 10,18 is currently manufactured using an enzymatic resolution of the 
earliest chiral intermediate in the synthesis. 19 As depicted in Scheme 1.5, the unwanted isomer 
is hydrolysed leaving the desired enantiomer as the substrate for further transformation. 
H3CO 
enzymatic · b 
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Scheme 1.5: Enzymatic route to diltiazem 
As illustrated by diltiazem, epoxides form intermediates in a vast number of syntheses and the 
kinetic resolution thereof using chiral metal complexes as catalysts is becoming a highly 
commercialised area of research. One of the newest such catalysts developed by Jacobsen at 
Harvard universilf0 has been licensed to ChiRex by the University. 
The most frequently used approaches for the separation of enantiomers on a commercial scale 
involve crystallisation processes. These were used in this work and are discussed in Section 1.2. 
Large scale preparative separation via chromatographic methods has not been used to any great 
extent to date but this option is becoming more viable with advances in the development of 
chiral stationary phases and moving bed technology. Another area of separation which holds 
great promise but is still in its infancy is that of enantioselective transport through membranes. 
The latter two separation methods are the topics of chapters in a recent review on chiral 
• 2 1 separatwns. 
5 
1.2 Racemate Resolution via Crystallisation 
1.2.1 Direct Crystallisation 
Racemate resolution via direct crystallisation is dependent on the occurrence of the crystalline 
substance as a conglomerate as opposed to a racemic compound. Although a bulk conglomerate 
is optically neutral, individual crystals contain only one enantiomer whereas crystals of a racemic 
compound are themselves racemic. Several methods are used for the identification of a 
conglomerate.22 These include comparison of the solid state infra-red spectra and the X-ray 
powder diffraction patterns of the racemate with those of an individual enantiomer. They will be 
-identical in the case of a conglomerate. It is estimated that only 5-10% of all organic compounds 
crystallise as conglomerates?3 Where salt formation of a molecule with an achiral acid or base 
is possible, the likelihood of a conglomerate increases 2-3 times.24 The first substance ever 
resolved, sodium ammonium tartrate, by Pasteur in 1848,25 crystallises as a conglomerate whilst 
tartaric acid is a racemic compound. The properties, behaviour and resolution of conglomerates 
is well understood and has been fully documented by Jaques, Collet and Wilen.24 
There are two main approaches to conglomerate resolution. In the first, the separation is based 
on the spontaneous resolution that occurs upon crystallisation. The individual crystals may be 
manually sorted in a process called triage, as by Pasteur, but this is obviously only suitable on a 
very small scale and is dependent on the crystals having hemihedral faces so that enantiomeric 
crystals can be recognised optically. A more practical alternative consists of the localisation of 
individual enantiomers on suitably positioned seed crystals within a supersaturated solution of 
the racemate. This method is used by Merck for the resolution of an intermediate in the 
synthesis of a-methyl-L-dopa.26 
The second approach is referred to as "preferential crystallisation" or "resolution by 
entrainment". It consists of collecting alternate crops of each enantiomer in a single vessel. 
Seeds of one enantiomer (say the (+)-enantiomer) are added to a solution artificially enriched 
with that isomer. A crop of material equal to twice the weight of the original enrichment is 
collected and replaced with an equal amount of racemate. The solution is then seeded with the 
(-)-enantiomer and the process repeated. These steps can theoretically be repeated ad infinitum, 
6 
but build-up of impurities in the solution prevents this. This method has been used for more 
than 30 years by Roussel-Uclaffor the production of chloramphenicol.27 
1.2.2 Resolution by Diastereomer Formation 
Unlike enantiomers, diastereomeric pairs may have significantly differing physical properties 
that can form the basis for their separation. When using crystallisation techniques, the 
separation depends entirely on differences in solubility. Diastereomeric pairs are usually 
considered in two broad categories, viz. covalent diastereomers and dissociable diastereomers. 
Resolution via covalent diastereomers is frequently used on a laboratory scale (often with 
chromatographic separations) but is not favoured in industry since the formation and cleavage of 
these compounds, and recovery of resolving agent, is usually more complex and prone to 
racemisation than that of dissociable diastereomers. 
Dissociable diastereomers include diastereomeric salts and complexes. The formation of 
crystalline diastereomeric salts between racemic substrates and optically active resolving agents 
is widely used industrially and provides a large proportion of those optically active drugs that are 
not derived from natural products. 10 This was the resolution process applied in this work and is 
described in more detail in Section 1.2.2.1 . 
There are, however, molecules of commercial interest such as 4-6 belo~8 which are devoid of 
suitable functionality for salt formation. These could be resolved by the formation of 
diastereomeric complexes which can be Lewis acid-base pairs, diastereomeric metal complexes, 
inclusion compounds and quasi-racemates. Compound 7 has been shown to form I: I inclusion 
compounds with 4-6 providing products of high optical purity.29 The cost of producing such 
chiral host molecules is often prohibitive and chiral pool materials are being explored as a 
departure point for the synthesis of hosts such as 8 (derived from (2S,3S)-tartaric acid) which has 
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1.2.2.1 Diastereomeric Salt Formation 
7 
OJC(Ph)20H 
0 ' ·C(Ph)20H 
8 
The process is referred to as "classical resolution" and was discovered by Pasteur in 1853 when 
he obtained the optically pure antipodes of tartaric acid by resolving with (+)-quinocine and(+)-
cinchonidine31 respectively. The process of diastereomeric salt formation between a racemic 
base (B) (such as albuterol) and an acidic resolving agent (A) can be summarised as follows: 
(±)-B + (-)-HA (+)-BH\-)-A + (-)-BH\-)-A 
racemate resolving agent n-salt p-salt 
The nomenclature used to describe the two salts stems from a proposal made by U gi32 in which 
the diastereomer resulting from enantiomers of like sign of rotation is referred to as the positive, 
or p-salt and that comprising enantiomers of unlike sign is thus the n-salt. This convention does 
not take the absolute configuration at any of the centres into account. 
If the difference in solubility of the two salts is large enough, the less soluble salt can be 
crystallised. The desired, optically pure enantiomer is then removed from the diastereomer and 












Despite this resolution technique having been investigated and used for over a century, it is still 
impossible to predict the course of a resolution24 and as a result, it is often viewed as being too 
"low tech" and empirical to warrant serious effort. A strategy toward such resolutions has been 
compiled by Wilen et az33 and success is frequently achieved on substrates bearing suitable 
functionality. The Andeno route to captopril, an ACE inhibitor which grossed $1670 million in 
sales during 1995/4 is via the optical resolution of an early intermediate35 which is later coupled 
to (S)-proline in order to introduce the second stereogenic centre (Scheme 1.6). 
AcS~CO H resolution using 




Scheme 1.6: Andeno approach to captopril 
Several approaches have been used in attempts to rationalise resolution results. Acs, Fogassy and 
co-workers have been able to evaluate and interpret the results of some optical resolutions by 
determining thermodynamic constants and X-ray structures.36•37 Acs has also analysed the chiral 
discrimination ability of tartaric acid in terms of a three-point interaction model.38 Separate 
studies on crystal structures of diastereomeric salt pairs by Gould39 and Amett40 both conclude 
that weak van der Waals interactions probably determine the course of a classical resolution. 
Viewing the problem from an entirely different angle, Ariaans et af1 have attempted to compute 
correlations between physical properties of resolving agents and resolution efficiencies using 
Principal Component Analysis, from which they concluded that parameters which relate to the 
chirality of the compound, e.g. measurable diastereomeric interactions, are required to obtain 
correlation. A quantitative approach has been taken in a study by Leusen42 in which 
experimentally determined lattice energies were compared to those determined using Molecular 
Mechanics calculations on X-ray data. Limitations in the computational methods presently 
available hampered accurate calculation of these energies. It is further pointed out by Leusen 
that most of the rationalisations put forward rely on known X-ray structures. In order to develop 
a truly predictive model, a method to predict crystal packing of the salts must be developed. 
This has thus far only been achieved for simple hydrocarbons.43•44 
9 
In contrast to the initial resolution, the optimisation thereof is a well understood area?
4 
The 
solubilities of a three component system (two diastereomers and one solvent) are represented in 
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Figure 1.2: Ternary phase diagram for unsolvated salts 
The diagram gives the solubility of each salt (points a and b) and of mixtures of the salts ( ae and 
be) in the solvent at a particular temperature. For many organic mixtures, the eutectic 
composition, c, is not very temperature dependent, thus simplifying the optimisation.45 
The following regions define four specific conditions the resolution mixture may be in: 
i) Saeb: both salts are unsaturated 
ii) aeP: solid p-salt is in equilibrium with a solution of both salts as defined by ae 
iii) beN: solid n-salt is in equilibrium with a solution ofboth salts as defined by eb 
iv) PeN: Saturated solution of composition c in equilibrium with solid p- and n-salts 
In a typical resolution experiment, an unsaturated 1:1 solution of the salts as represented by d 
will be prepared. As the solvent volume decreases d will descend down tie line Sm to point f 
where the less soluble p-salt becomes saturated and begins to crystallise. Further removal of 
much solvent can result in the saturation of the solution with respect to the undesired n-salt as 
well (point g) and the salts will crystallise together. 
Construction of such a diagram is a tedious process and requires the availability of both salts, but 
it should be undertaken during the development phase of industrial resolutions where the gains 
in both chemical and optical yield would be economically significant. 
10 
1.3 Racemisation 
Where a resolution step is used to produce a single enantiomer, the ability to racemise and 
recycle the unwanted enantiomer frequently determines the economic viability of the process. 
The ideal situation in a resolution occurs when it can be carried out under conditions in which 
the enantiomer or diastereomer remaining in solution undergoes spontaneous epimerisation. The 
once-through theoretical yield thus increases from 50% to 100%. When crystallisation is the 
mode of resolution, the overall process constitutes a crystallisation-induced asymmetric 
transformation. This is illustrated by the industrial synthesis of the Eli Lilly analgesic, 






DOBT = Di-(0)-Benzoyltartaric acid 
i) precipitation of 
least soluble salt 
ii) basic workup 
N(CH3)z 
dextropropoxyphene 
Scheme 1.7: Industrial synthesis of dextropropoxyphene using a crystallisation-induced 
asymmetric transformation 
Chiral an1ines and amino acids are susceptible to racemisation via transient, reversible Schiff 
base formation in the presence of catalytic amounts of carbonyl compounds. This has been 
applied in one-pot resolution procedures for multikilo syntheses of amine intermediates.47,48 
Where there is no possibility for such one-pot procedures, standard racemisation techniques, 
such as base-mediated enolisation, are applied to the isolated unwanted diastereomer or 
enantiomer. These have been reviewed by Eliel et al. 22 
11 
1.4 Determination of Enantiomer and Diastereomer Composition 
The most common way to describe stereoisomer mixtures is as the excess of one stereoisomer 
over the other (as a percentage). The enantiomeric excess is thus given by: 
(X -X) ee = 100 R s 
(XR + Xs) 
where 
XR = no of moles (R)-enantiomer 
Xs = no of moles (S)-enantiomer 
The scope of analyses employed is large and these have been reviewed and summarised as 
presented in Table 1.1 below?2 
Table 1.1: Methods for the determination of Enantiomer and Diastereomer composition 












Nature of Measurement 
Optical rotation, a 
Circular polarisation of emission 
NMR-diastereomers in achiral solvents 
NMR-enantiomers in chiral solvents 
NMR-with chiral shift reagents 
Chromatography on diastereoselective stationary phases: 
gc, hplc, tic 
hplc with chiral solvent 









gc, hplc, tic E 
Electrophoresis with enantioselective supporting electrolyte E 
Product composition DorE 
Quantitative enzyme-catalysed reaction E 
Differential scanning calorimetry DorE 
Isotope analysis E 
Potential of an electrochemical cell E 
E = enantiomer D = diastereomer 
12 
1.5 Albuterol 
It is estimated that 5% of Western society will suffer from bronchial asthma at some time in their 
lives.49 The disease is characterised in its early stages by breathlessness and wheezing due to 
constriction of respiratory smooth muscle, which is easily reversed by the administration of a 
bronchodilator. Of the bronchodilators, the P2-adrenergic receptor agonists produce the greatest 
effects and albuterol 3 is preferred as a first choice treatment for relief of these acute 
symptoms. 5° The drug was developed in the late 1960's, in a process that has been reviewed by 
Lunts, 51 and marketed as a racemate. The assignment of absolute configuration of the 
enantiomers of albuterol was achieved in 1971 52 and these are illustrated in Fig. 1.3. The 
bronchodilatory activity was shown to reside largely in the (R)-enantiomer. More recently, the 
realisation that the "inactive" enantiomers of the P2-adrenergic receptor agonists may be 
associated with toxic effects, as well as the need to investigate the relationship between 
enantiomers and side effects, which include tremor and reduction of renal function, 53 have led to 
a number of publications54-56 and culminated in the submission of an NDA (New Drug 




( R)-(-)-albuterol ( S)-( + )-albuterol 
Figure 1.3: The enantiomers of albuterol 
1.5.1 Synthesis of(rac)-Albuterol 
Albuterol has been the target of a number of synthetic approaches which have recently been 
reviewed. 53 Along with standard functional group manipulations, three types of reaction utilised 
in the syntheses stand out: electrophilic aromatic substitutions, nucleophilic addition or 
condensation with a t-butylamine, and reduction of carbonyl groups to the corresponding 
hydroxymethylene groups. These concepts are illustrated in a typical industrial route to 
albuterol57 (Scheme 1.8). 
13 
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Scheme 1.8: Synthesis of (rac)-albuterol from 4-hydroxyacetophenone. 
1.5.2 Synthesis of (R)-Albuterol 
The most successful asymmetric synthesis of albuterol in homochiral form is based on 
enantioselective reduction using chiral oxazaborolidine catalysts.58•59 Optimum results were 






















Scheme 1.9: Asymmetric synthesis of (R)-albuterol from methyl-5-acetylsalicylate 
Difficulties in the classical resolution of (rac)-albuterol have been reported.52 The best result 
obtained in recent studies has been resolution with (S)-naproxen to produce (R)-albuterol with an 
ee of 86% and in 15% yield. 58 More success has been attained in resolving advanced 
intermediates of albuterol. 
14 
The first preparation of optically pure (R)-albuterol was via resolution of the doubly benzylated 
methyl ester 10 with (+)-di-0-toluoyltartaric acid which gave a 30% chemical yield in 97% ee.
52 
Reduction of the resolved base with lithium aluminium hydride, followed by catalytic 
debenzylation gave (R)-albuterol which was characterised as an acetate salt. Other intermediates 
resolved include the benzyloxyarylethanolamine ester 11 with (+)-di-0-benzoyltartaric acid 
(37% yield, 95% ee on the resolution step),58 arylethanolamine ester 12 with (+)-di-0-
toluoyltartaric acid (30% yield, >99% ee)60 and benzylated albuterol 13 with (+)-di-0-
benzoyltartaric acid (37% yield, >99% ee).61 A process based on the last of these resolutions has 








Resolution of albuterol via salt formation with a metal complex was reported in 1973.62 This 
involved the addition of (+)-Ba[CoEDTAh to a solution of (rac)-albuterol in dilute H2S04. 
After filtration to remove precipitated BaS04, the desired diastereomeric salt was precipitated by 
the addition of EtOH and Et20. (R)-Albuterol was recovered as the hydrochloride salt by 
addition of BaC12 to a solution of the diastereomeric salt in H20 followed by precipitation of the 
resolving agent to leave the product which was then precipitated from the solution. 
1.5 .3 Determination of Enantiomer Composition of Albuterol 
Apart from the traditional optical rotation measurements, other more recent approaches to the 
analysis of the enantiomer composition of albuterol have been reported. 
Analytical Separations have been performed by HPLC and capillary electrophoresis on chiral 
stationary phases. High performance liquid chromatographic separation has been achieved on a 
chiral a 1-acid glycoprotein column
63 as well as a Pirkle-brush colurnn.64 The electrophoretic 
separation was accomplished using a cyclodextrin stationary phase.65 
15 
NMR techniques used include the addition of either a lanthanide shift reagent66 or 0-
acetylmandelic acid (as a chiral solvating agent)67 to allow the discrimination of the enantiomers 
of albuterol, which are quantified by the integration of suitable peaks in the spectra produced. 
1.6. The Approach taken in this work 
The objective of this work was to produce (R)-albuterol using crystallisation techniques. As is 
evident from Scheme 1.8, the chiral centre is introduced late in the industrial syntheses of 
albuterol. The classical resolutions discussed in Section 1.5.2 are on intermediates other than 
those found in the routine synthesis of (rae )-albuterol. Producing these intermediates requires 
selective reduction of a suitably protected carbonyl compound with lithium aluminium hydride 
to give one of compounds 10- 13. These are then resolved and deprotected, as in the last step in 
Scheme 7, resulting in (R)-albuterol. The strategy adopted in this work was to produce a 
resolution target by the derivatisation of readily available (rac)-albuterol, rather than altering the 
routine synthesis of the drug. In order to compete with the resolutions described above the target 
sought needed to be produced in a single step with economically viable reagents. The same 
holds for the conversion of the resolved target back to (R)-albuterol. In selecting a target, the 
criteria used as a guide by ten Hoeve and Wynberg in the design of synthetic resolving agents68 
were considered, in particular the preference for rigidity in the compound. 
In order to introduce rigidity into albuterol, the ketal 14 or oxazolidine 15, were selected as 
resolution targets. Such protection reactions require symmetrical ketones such as acetone (R = 
CH3) or benzophenone (R = Ph) in the presence of an acid catalyst whilst the deprotection is 




The work described in this thesis investigates the formation of a target derivative and the 
resolution thereof. Further synthetic and structural work performed in order to verifY the 
absolute configuration of the resolved derivative is also described. 
16 
CHAPTER2 DERIVATISATION AND RESOLUTION STUDIES 
2.1 Derivatisation of Albuterol 
The isopropylidine derivatives of albuterol, 16 and 17 were those first targeted. Since both 
acetonide and oxazolidine formations utilise the same reaction conditions, it was hoped that the 
nature of the substrate would allow some chemoselectivity. Although formation of the 
diprotected adduct, 18 would lead to futher reduction in the conformational freedom of the 
molecule, it would also block all functionality capable of hydrogen bonding. This was 
considered undesirable since intermolecular hydrogen bonding is a major contributor to the 
stability of the lattice in crystalline compounds. 69 It was rationalised that oxazolidine formation 
was more likely than ketalisation due to the superior nucleophilicity of an amine nitrogen in 
comparison to that of a hydroxyl oxygen. 
Protections of this nature are traditionally carried out using dry acetone in the presence of an acid 
catalyst.70 Refluxing of (rac)-albuterol in an excess of acetone with p-toluenesulfonic acid did 
not produce any reaction. Since a molecule of water is formed in the protection reaction, some 
means of dehydration is required. Azeotropic removal of water with toluene or benzene was not 
possible due to the insolubility of the polar starting material in these solvents and the low boiling 
point of acetone. An alternative method for isopropylidine ketal formation involving acetal 
exchange using 2,2-dimethoxypropane, was attempted. In this process, two moles of methanol 
are liberated with the equilibrium usually favouring complete product formation.71 No change, 
however, was observed in the reaction with albuterol. 
The use of a Lewis acid activator, BF3·0Et2, which would consume water or methanol produced, 
was thus introduced. In an excess of 2,2-dimethoxypropane, an inseparable mixture of products 
was produced, but a major product, 19, could be isolated from the reaction between albuterol and 
3 equivalents each of acid and 2,2-dimethoxypropane in dichloromethane (Scheme 2.1 ). The 1 H 
NMR shifts (3.16 and 3.44 ppm) for the new methyl protons of the product indicated that 
17 
methylation of both benzylic hydroxyl groups as opposed to the phenol or amine moieties (Ar-




The observed methylation was a surprising result since, according to literature precedent, under 
acidic conditions, heteroatom attack at the ketal carbon of dimethoxypropane was expected. A 
plausible explanation for the methylation outcome is that methyl transfer from the methylated 
oxocarbenium ion, as shown in Scheme 2.2, took place. The chemoselectivity of methylation 
can be rationalised in terms of the relative hardnesses of the nucleophiles concerned. The harder 
oxygen nucleophile is preferred by the relatively hard methylating agent to the nitrogen 
nucleophile which is, in any event, quite sterically hindered. Clearly, of the three oxygen sites, 
the phenolic centre is of a much reduced nucleophilicity due to resonance. The issue of 0 versus 
N chemoselectivity re-emerges in Chapter 3. 
- - - )=o + R-o--CH3 
Scheme 2.2 
By comparison, the BF)'OEh catalysed condensation of acetone and albuterol yielded a single 
product which was identified as the isopropylidine ketal of albuterol, 16 (Scheme 2.3). The 1H 
NMR spectrum revealed two singlets integrating for 3 protons each at 1.505 and 1.510 ppm 
respectively which confirmed the presence of diastereotopic methyl groups as expected from the 
formation of an isopropylidine derivative. The t-butyl methyl and benzylic methylene protons 
which both give rise to singlets, and the assignment of other protons was made on the basis of 
the coupling present. The geminal protons 2-HA and 2-H8 constituted the AB portion of an ABX 
system with 1-H, and both resonated as double doublets at 2.56 and 2.80 ppm respectively CJA,B 
= 11.7 Hz, JA,x = 9.0 Hz, Js,x = 3.5 Hz). The doublet of doublets for 1-H was located further 
downfield at 4.50 ppm. The aromatic protons 7'-H and 8'-H showed vicinal coupling (J 8.3 Hz), 
while an expected W-coupling was observed between 7'-H and 5'-H (J 1.6 Hz). These coupling 
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motifs were used to aid assignments in the spectra of all albuterol-based compounds synthesised 
in this work. 13C-1H correlation spectroscopy (HETCOR) was used to assist in the assignment 
of the 13C spectrum. The expected chemical shift for the acetal carbon in a 2,2-dimethyl-1 ,3-
oxazolidine is ~81 ppm whilst that in the analogous 1,3-dioxane is ~99 ppm.73 The observed 
shift for C-2', 99.5 ppm, thus indicated acetonide formation. The crystal structure of (+)-16 
confirmed the integrity of the acetonide (See Section 3.3). Since the reaction is under 
thermodynamic control, this unexpected chemoselectivity is ascribed to the thermodynamic 
preference for the 6-membered 1 ,3-dioxane over the oxazolidine in which some severe steric 
interactions, notably t-butyl versus the phenyl ring and dimethyl substituents, exist. 
acetone 
Scheme 2.3 
Acetonide formation was also achieved when reacting acetone and albuterol in the presence of 
H2S04. A series of experiments were conducted on a 4 mmol scale and at 0°C in order to 
optimise the conditions for both the Lewis acid and mineral acid catalysed reactions. The results 
of these are summarised in Table 2.1. 
Table 2.1: Optimisation of albuterol acetonide formation 
Exp. Acid Equiv.a Dehydrating Equiv. Rxn Time Yield Impuritiesc 
agent {min2 {%t 
1 BF)"0Ei2 2 10 87 ~3% 
2 BFJ"OEt2 2 60 95 <1% 
3 BF)"0Ei2 3 10 90 ~5% 
4 H2S04 1 60 100 ~3% 
5 H2S04 2 60 104 ~5% 
6 H2S04 2 CuS04 2 10 102 ~1% 
7 H2S04 1.5 CuS04 0.5 30 100 ~3% 
8 H2S04 3 CuS04 1 30 109 ~10% 
a equivalents = moles acid used per mole albuterol 
b based on mass of crude material 
c as by-products and/or starting material which were demonstrated by tlc and quantitated 
by 1H NMR of crude material 
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From Table 2.1 it can be concluded that greater that one equivalent of H2S04 or H2S04 with 
CuS04 does not drastically increase the yield. Where more than two equivalents of acid were 
used, the impurity migrated on tlc as a less polar spot. This impurity could not be isolated 
cleanly for full characterisation, but 1 H NMR indicated the presence of the diprotected adduct, 
18. Although chromatographic purification was used in the experiments quoted in the 
experimental section, Chapter 5, no impurities could be detected by tlc or 
1
H NMR after a single 
recrystallisation of the crude material from acetone or acetonitrile. 
All efforts to produce the 2',2'-diphenyl analogue of albuterol isopropylidine ketal by 
condensation of albuterol with benzophenone were unsuccessful. This was probably because of 
the reduced electrophilicity of the carbonyl carbon due to resonance, as well as the additional 
steric crowding of the ketone by the phenyl substituents. 
2.2 Space Group Determination of Albuterol Acetonide, 16 
Of the two main approaches to resolution using crystallisation techniques, direct crystallisation is 
preferred over diastereomeric salt formation since no resolving agent is required in the resolution 
process. In order to decide if direct crystallisation was applicable to the resolution of (rac)-16, it 
was necessary to determine whether the material was crystallising as a conglomerate or a 
racemic compound. The comparative methods mentioned in Section 1.2.1 could not be used 
since no resolved material was available for comparison to the racemate. This necessitated the 
use of X-ray methods to determine the space group of (rac)-16, which allowed distinction 
between a conglomerate and a racemic compound. 
The first oscillation photograph of a single crystal of this compound, grown from acetone, 
showed the presence of a mirror plane. Reflections in the zero level Weissenberg showed two 
further mutually orthogonal mirror planes and from these two photographs, which indicated 
mmm Laue symmetry, the crystal system was established to be orthorhombic. In addition to 
extensive precession photography, cone-axis photographs were recorded. These yielded the 
fo llowing preliminary cell constants: 
a=25.3A b = 41.1A c = 6.0 A 
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Photographs of the general layers showed the condition: h + k = 2n which is consistent with a C-
centred lattice. The photographs also revealed the following conditions limiting possible 
reflections: 
Okl (k = 2n) 
hOl (h = 2n) 
hkO h=2n, k= 2n 
hOO (h = 2n) 
OkO (k = 2n) 
These data are indicative of two possible space groups, Cmma (No. 6i4) and Crn2a (a non-
standard setting of Abm2, No. 3974), with the former group being centric and the latter acentric. 
An intensity data collection was performed and the intensity statistic (IE2 - 11) compared to 
theoretical values in an attempt to assign the space group present as either centric or acentric: 
Data 
0.896 
Theoretical - Centric Theoretical - Acentric 
0.968 0.736 
No unambiguous conclusions about the centricity of the crystal could be made from these values. 
Attempts to elucidate the structure in either space group using direct methods failed, despite 
many trials with the program SHELX-8675 using both default and modified approaches. This 
failure was ascribed to the presence of pseudosymmetry which manifested itself in some unusual 
features on the X-ray photographs. Firstly, diffuse streaking was noted in alternate reciprocal 
lattice rows running parallel to the b* axis. Secondly, the additional condition h = 4n was noted 
on the hOI photograph as well as k = 4n along OkO. These conditions do not relate to any 
orthorhombic space group and are thus ascribed to the presence of pseudosymmetry. However, 
although assignment of the correct space group was not completed, both of the possible space 
groups contain mirror planes, thus necessitating the presence of both enantiomers of a chiral 
molecule in the crystal. The crystalline material was thus established to be a true racemate and 
resolution via diastereomeric salt formation was the necessary approach. 
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2.3 Diastereomeric Salt Formation 
Owing to the lack of predictability of the resolution step, the crystallisation array strategy 
advocated by Wilen et aP3 was followed. The following components were included in the pilot 
study: 
(i) Resolution substrates (bases): albuterol3 and albuterol acetonide 16. 
Parallel arrays were performed on both bases in order to confirm the reported lack of success in 
resolving albuterol. 
(ii) Resolving agents (acids):The acids listed below were available 
(1R)-(-)-Camphor-10-sulfonic acid (CSA) 
(2R,3R)-(-)-Di-0-benzoyltartaric acid monohydrate (DOBT) 
(S)-(-)-Malic acid (MA) 
(2R,3R)-(+)-Tartaric acid (TA) 
(S)-(+)-Mandelic acid (MDA) 
In addition, (S)-(+)-1,1'-Binaphthylphosphoric acid (BNP) was prepared in 85% yield and 98% 
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Scheme 2.4 
(ii i) Solvents: methanol, ethanol, acetone and ethyl acetate. 
A statistical analysis by Jaques et az24 of solvents used in over 800 resolutions showed that 
alcohols, acetone, water and mixtures of solvents containing alcohols were used in 90% of the 
cases. Water could not be used here due to the insolubility of 16, so ethyl acetate, as the next 
most prevalent solvent, was included. 
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Crystallisation was induced by slow cooling followed by slow evaporation of the solvent. 
Where suitable material was obtained, the melting point was measured and compared to the 
melting point of the components to give an indication of the formation of a new species. The 
results of the trial arrays are summarised in Tables 2.2 and 2.3 and the notes which follow. 
Table 2.2: Experiments with albuterol (3) as base 
Acid Methanol Ethanol Ethyl acetate Acetone 
(+)-BNP Paste Paste Insoluble Paste 
(-)-DOBT Oil Oil Insoluble Oil 
(-)-CSA Oil Paste Insoluble Paste 
(-)-MA Oil Oil Insoluble Insoluble 
(+)-TA Oil Crystalline (a) Insoluble Insoluble 
(+)-MDA Oil Oil Insoluble Insoluble 
Table 2.3: Experiments with albuterol acetonide (16) as base 
Acid Methanol Ethanol Ethyl acetate Acetone 
(+)-BNP Paste Paste Crystalline (b) Paste 
(-)-DOBT Crystalline (c) Crystalline (d) Powder Powder 
(-)-CSA Oil Paste Paste Crystalline (e) 
(-)-MA Oil Paste Insoluble Oil 
(+)-TA Oil Paste Insoluble Crystalline (f) 
(+)-MDA Oil Oil Oil Oil 
(a) A few crystals were obtained on slow evaporation of the solvent. These melted at 99°C 
which is unique. Attempts to repeat this experiment resulted in the formation of oils. 
(b) The crystals obtained on slow evaporation decomposed from 290°C. These are likely 
to be crystals of the resolving agent (lit. mp 300°C dec.). 
(c), (d) Fine crystals formed on cooling which melted at 185-195°C which is unlikely to be 
either resolving agent (lit. mp 90°C) or base (mp 91 °C). 
(e) Crystals were obtained on complete solvent evaporation and these decomposed from 
190°C which is similar to the melt of the resolving agent (lit. mp 198°C dec.). 
(f) Crystallisation occurred on solvent evaporation. The melt at 90°C coincided with that 
of 16 (91 °C) 
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The DOBT/16 series of experiments appeared most worthy of further investigation and that in 
methanol was repeated on a larger scale, using the non-hydrated resolving agent, in order to 
allow further characterisation of the solid material obtained. Salt formation between (2R,3R)-
(-)-di-O-toluoyltartaric acid (DOTT) and 16 was also attempted and proceeded in a similar 
fashion. 
A recent study on the diastereomers formed between pipecolic acid anilides and DOBT shows 
that for 50% of the species studied, the diastereomers formed were complexes as opposed to 
salts. 77 In addition, when salts were formed, the acid and base were present in a 1 :2 ratio 
whereas the ratio for complexes was 1:1. The infrared spectra for the DOBT and DOTT 
diastereomers formed here showed a broad band centred around 2700 cm-1 and a strong band at 
1640 cm-1 which were assigned as ammonium N-H and carboxylate C-0 stretching frequencies 
respectively. Those in the non-ionised species would have absorbed at -3400 and 1720 cm-1 
respectively, thus confirming that the species formed were, indeed, salts. The 1H NMR spectra 
were run in DMSO and that for the DOBT salt has been reproduced in Fig. 2.1 on page 24. 
Comparison of the integrals for the peak assigned to the t-butyl methyl protons (1.13 ppm) and 
the DOBT methine proton (5.66 ppm) gives a 9:1 ratio of protons. This is consistent with a 1 :2 
acid:base salt. Microanalysis confirmed this result for the salts of both acids. These results were 
in contrast to DOBT or DOTT resolutions of other protected albuterol derivatives52•58-61 in 
which, although no experimental evidence is presented, the implication from diagrams is that 1 : 1 
salts were formed. The 1:2 ratio is advantageous industrially since a maximum of 0.5 
equivalents of resolving agent is required in the resolution. 
Further resolution experiments were performed with the acid and base being combined in 1 :2 
proportions. The solvent was removed from the mother liquors of a crystallisation experiment 
with each salt and the resulting material dried under vacuum to give a colourless solid. Optical 
rotations ofthe precipitates and mother liquors were determined: 
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Two conclusions could be drawn from these results: firstly, the disparity between the rotations of 
the mother liquor and the precipitate indicated that some enantiomeric enrichment had taken 
place and secondly, because the precipitate rotation was less negative, that the ( + )-16/(-)-acid 
salt, i.e. the n-salt was that precipitating. 
The enriched ketal was extracted in very high yield from each of the precipitates in a basic work-
up procedure to give an optical rotation of + 16° in each case. Since the absolute rotation of 
either enantiomer of 16 was unknown, alternative means of evaluating resolution efficiency was 
required and those applied are discussed in Section 2.4. Acidification of the aqueous phase from 
the ketal recovery allowed extraction of the resolving agent into ethyl acetate. Both resolving 
agents were recovered in high yields (>95%) and optical purity (>97% ee). 
The absolute configurations of the enantiomers of 16 were also unknown when these 
experiments were started. A series of experiments on the resolved material were undertaken in 
order to establish this and these are described in Chapter 3. Hydrolysis of this material (see 
Section 2.6) gave rise to (S)-(+)-albuterol acetate. Since the (R)-enantiomer is that desired, 
further resolution work was undertaken using (2S,3S)-(+)-DOBT and (2S,3S)-(+)-DOTT and the 
salts referred to in the remainder ofthis work are (R)-16/(2S,3S)-DOBT, 20 and (R)-16/(2S,3S)-
DOTT, 21 (Fig 2.2). The (2S,2S)-resolving agents are derivatives of unnatural tartaric acid 
which are more expensive than those of the natural (2R,3R)-isomer. They are, however, also the 
enantiomers required in the aforementioned resolutions of compounds 10-13. A recent 
resolution of DOBT by preferential crystallisation of its calcium salt-methoxyethanol complex 78 
provides a route that should lead to cheaper sources of these resolving agents. 
20 
Figure 2.2: DOBT and DOTT n-salts of 16 
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2.4 Determination of Enantiomeric Purity 
2.4.1 1H-Nuclear Magnetic Resonance 
(R)- or (S)-0-acetylmandelic acid (OAM) forms soluble diastereomeric salts with a wide range 
of chiral amines and amino alcohols, thus permitting a direct measure of their enantiomeric 
composition by NMR spectroscopy.67 The spectrum for (rac)-16 with (R)-OAM in CDCh was 
recorded at 0°C (400 MHz) and is reproduced in Fig. 2.3 on page 27. The expansions shown 
indicate a number of areas where chemical shift non-equivalence is observed for the 
diastereomers. In the literature report on OAM, the peaks for the methylene group a- to the 
amine in albuterol were simplified by simultaneous irradiation of the adjacent methine proton, 
and the integrals determined. In the spectrum obtained here, the obvious peaks to use for 
quantitative work were those of the t-butyl methyl protons (8~ 1.2 ppm) since they were 
uncomplicated singlets, and because of the increased sensitivity achieved by integrating for a 
higher number of protons. A spectrum for a resolution sample of (R)-16 ( -80% ee) is shown in 
Fig. 2.4 on page 28. 
Although the shift non-equivalence was found to be higher at 0°C (L18 = 0.10 ppm), the spectra 
run at room temperature showed suitable resolution (L18 = 0.05 ppm) of the peaks being used. 
Use of this method was, however, limited by a lack of sensitivity due to: (i) the enantiomeric 
purity of the OAM used (98% ee) and (ii) the inherent limits of quantitative NMR for which 
limit of detection is estimated to be approximately 2%. 13 
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H NMR spectrum of(R)-16 with (R)-OAM in CDCh 
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2.4.2. High Performance Liquid Chromatography 
Separation of the enantiomers of albuterol by a commercially available Pirkle-type chiral 
stationary phase formed by a urea linkage between (R)-1-( a.-naphthyl)ethylamine and (S)-
indoline-2-carboxylic acid, and which is grafted onto silica gel, has been demonstrated.64 The 
likely stereoselective sites of interaction of this stationary phase are illustrated in Fig. 2.5.79 
Apart from the reduced number of sites for hydrogen bonding, the interactions of 16 with this 
phase should be similar to those of albuterol. 
H3C--. 
hydrogen - 0\'NH '\ n-n interaction J ~~,_;:::;~~~o--(0 ~- steric hindernnce 
Figure 2.5: Possible stereoselective sites of interaction on the chiral stationary phase used 
Separation ofthe enantiomers of 16 was achieved on this column using a less polar mobile phase 
than that used for albuterol. A typical chromatogram for a racemate sample is reproduced on 
page 31 (Fig. 2.7(a)) The earlier eluting peak is that of the (S)-enantiomer (retention time 10.7 
min) while (R)-16 elutes at 12.5 min. This order of elution is desirable since, if it were reversed, 
(S)-16 as the small impurity peak would elute on the tail of the major (R) peak in sample 
solutions. 
Samples were initially prepared by dissolution in the mobile phase (hexane/1 ,2-
dichloroethane/methanol/trifluoroacetic acid 2401140/7.511 ), but decomposition was noted over 
a 12 hour period. The solutions were stable when trifluoroacetic acid was removed from the 
solvent. 
A series of standards of the racemate were prepared and injected in order to determine the limit 
of quantitation and ensure linearity of the response. The results (areas of the (S)-peak) are 
presented in Table 2.5. At concentrations lower than 0.044 mg.cm·3 the reproducibility of 
integration was unsatisfactory. A concentration of 0.044 mg.cm·3 of the racemate gives 0.022 
30 
mg.cm·3 of either enantiomer which relates to an ee of 99.56% when a 10 mg.cm-3 sample 
solution is injected. The limit was thus set at 99.5% ee for samples of this concentration. Linear 
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Figure 2.6: Calibration curve for (S)-16 
In the sample determinations, the areas of the enantiomer peaks were compared in order to 
determine ee as an alternative to use of the calibration curve to determine the actual content of 
(S)-16 in the sample. The reasons for this were twofold: (i) the solutions were prepared in very 
small volumes (1 cm3) and the relative proportion of each enantiomer present is independent of 
this volume which is likely to have a degree of error attached and (ii) the purpose of the 
determination was to evaluate resolution efficiency and not overall purity. A typical sample 
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Figure 2.7: Chromatograms showing the separation of the enantiomers in: 
(a) a 0.440 mg.cm-3 solution of(rac)-16 
(b) a sample of(R)-16 (>99.5% ee). 
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Once a sample of 100% (R)-16 had been produced, the [a ]o for the compound in methanol was 
determined as -18.9° and rotation could then be used as a preliminary measure of enantiomeric 
purity. 
The calibration exercise undertaken for 16 was repeated on (rac)-albuterol. The retention times 
for the peaks, which eluted in the same order as 16, were 16.9 and 19.9 min respectively. The 
material was insoluble in the sample solvent and was thus dissolved in a minimum of methanol 
and then diluted with sample solvent. The sample concentrations had to be reduced since a high 
methanol content resulted in poor chromatography. The quantitation limit was set at 0.023 
mg.cm-3 racemate which gave a 99.5% ee limit for a 5 mg.cm-3 solution. Regression again 
revealed a linear relationship (R squared = 0.99997). The treatment of sample data was as for 
16. 
2.5 Resolution studies 
1H NMR shift experiments on the initial resolutions performed showed the enantiomeric 
excesses to be approximately 90%. This increased to 97% after a single recrystallisation of 
resolved 16. These positive results led to further investigation of the resolution by both acids. 
With suitable means of evaluation in place, a number of experiments were attempted in order to 
determine the effect of certain variables on the resolutions. In each case 16 was extracted from 
the salts (either 20 or 21) and the enantiomeric purity of the crude extract determined by the 
method indicated. Yields are those based on 1 00% being the full recovery of a single 
enantiomer. 
Parallel resolution experiments with DOBT in ethanol were performed on the crude material 
isolated from both BF3·0Et2 and H2S04 catalysed preparations of 16, and compared to the 
resolution of a recrystallised sample. As is evident from the table below, the chemical yield, 
more than the optical purity, was affected by the sample purity. 











Since the above resolutions from ethanol were considerably poorer than those from methanol, 
DOBT resolution was investigated for solvent dependence. The acid and base were each 
dissolved in warm solvent and the acid solution added to the base to give a 20 mg.cm-3 solution 
with respect to 16. The precipitate produced from ethyl acetate .was so fme that any filter used 
clogged and no meaningful results could be obtained. The other results are summarised in Table 
2.7. 
Table 2.7: Solvent dependence ofDOBT resolution (optical rotation) 
Methanol 
Yield(%) 34 







Although the results for these resolutions were encouraging, the reproducibility between sets of 
experiments was unsatisfactory. It was felt that the temperature of the component solutions 
being added together, the rate of addition, and the rate of cooling of the diastereomer mixtures 
were also influencing the outcome of the resolutions. The optimisation of all these parameters, 
since demanding in terms of both material and time, was not undertaken in this study. 
As a comparison of the DOBT and DOTT resolutions, parallel experiments as described in 
Chapter 5 (synthesis of 20 and 21) were performed, with extreme care being taken to keep the 
aforementioned variables constant. These results are tabulated below. 
Table 2.8: Comparison ofDOBT and DOTT resolutions of 16 (hplc) 
Resolution Stage DOBT DOTT 
First precipitation of salt Yield 70 90 
ee (%) 89.5 92.1 
Recrystallised salt Yield 63 80 
ee (%) >99.5 95.5 
The DOTT resolution was more successful in the initial stage but purification by recrystallisation 
of the salt was not successful due to the insolubility of 21 in most organic solvents. The sample 
here was slurried rather than recrystallised. The concentration of salt in the recrystallisation 
solvent was maintained for 20 in order to allow comparison with 21, although a lower volume of 
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solvent was maintained for 20 in order to allow comparison with 21, although a lower volume of 
methanol would have sufficed for complete dissolution. The recrystallisation of 20 provided a 
notable improvement in optical purity but the yield was low. The use of a less polar solvent or a 
smaller volume of methanol may provide an optimised result. . The (R)-16 obtained from the 
DOTT resolution was recrystallised three times from acetone, resulting in the following 
improvement to the ee: 95.5 ~ 99.5 ~ >99.5 ~ no (S)-16 detected. The construction of 
ternary phase diagrams (described in Chapter 1) for the DOBT and DOTT salts in likely 
resolution and recrystallisation solvents, as well as for the enantiomers of 16 in recrystallisation 
solvents would allow determination of: (i) the optimum conditions of the resolution, and (ii) the 
stage in the procedure at which to purify resolved material. 
2.6 Hydrolysis of Albuterol Acetonide 16 
In a recent publication by Effenburger and Jager, 17 difficulties in the acid hydrolysis of the (R)-
albuterol ketals 22 and 23 was described. When HCl was the acid used, racemisation and 
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As a protecting group for 1,2 and 1,3 diols the isopropylidine ketal in 16 is usually preferred to 
the methylene or ethylidine equivalents in 22 and 23, because it is the most reactive towards acid 
hydrolysis. It is thus surprising that synthesis of (R)-16 was not attempted in the Effenburger 
study. 
Hydrolysis of isopropylidine ketals at mild temperatures has been achieved with acetic acid. 80 A 
number of reaction conditions were explored in the acetic acid hydrolysis of 16 and complete 
reaction was only achieved in those in which acetic acid/water 50/50 was used in a 20-fold 
excess as the solvent for the reaction. When heated to reflux, the reaction was complete in 1.5 
hours. The reaction time increased to 6 hours when the solution was stirred at 50°C. In both 
cases decomposition products were only detected well after completion of the reaction. 
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Isolation of the hydrolysed product from the reaction proved problematic. Since albuterol is 
soluble in water, standard basic work-up conditions to isolate the free base were not viable. It 
was thus decided to isolate the albuterol as an acetate salt, as in the first separation of the 
enantiomers of albuterol.52 Attempted azeotropic removal of the excess reagents with toluene 
resulted in decomposition of the product when low volumes were reached. Vacuum distillation 
at 40°C allowed removal of the reagents without any decomposition of albuterol. The oil formed 
was taken up in methanol and addition of ethyl acetate prompted precipitation of the product, 
albuterol acetate monomethanolate 24, in 92% yield. 
Hplc was used to determine the effect of the hydrolysis conditions on the enantiomeric purity of 
the material. A (R)-albuterol ketal sample of >99.5% ee was hydrolysed at 50°C as described 
above. Once reaction was complete, an aliquot of the reaction mixture was taken and most of 
the water removed by azeotroping with isopropyl alcohol. The sample was then diluted as for 
solid samples. Hplc analysis revealed the enantiomeric excess of the material to be unchanged. 
The reaction mixture was then refluxed for 2 hours. Hplc showed the presence of some early 
eluting impurities, as well as a decrease in the ee to 97. 7%, thus demonstrating that higher 
temperatures are required in order to effect racemisation by acetic acid. A sample of (R)-16 of 
lower enantiomeric purity (95.5% ee) was similarly hydrolysed in order to determine the effect 
of the isolation procedure on ee. The enantiomeric excess of the crystalline (R)-24 isolated was 
determined at 97.0% ee. Recrystallisation of 24 thus provides another opportunity for 
optimisation of the optical purity of the product and, as before, the construction of a phase 
diagram in order to determine the eutectic of 24 in various recrystallisation solvents would allow 
evaluation of this as a purification step. The optimised hydrolysis procedure is illustrated in 





Scheme 2.5: Hydrolysis of(R)-16 
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Characterisation of (R)-24 was not straightforward owing to its crystallisation as a methanol 
solvate. Inconsistent microanalytical results were obtained due to partial desolvation on drying. 
Thermogravimetric analysis (Fig. 2.8) of a sample freshly removed from the mother liquor 
showed a mass loss of approximately 10% over the range 80-140°C which is as expected for the 
inclusion of one molecule of methanol per salt formula unit (Theoretical mass loss = 9.7%). 
This is followed by mass loss due to decomposition of the salt after melting of the desolvated 
crystal at 144 °C. The trace produced by differential scanning calorimetry over the same 
temperature range, also reproduced in Figure 2.8, shows two endotherms confirming these two 
events ( desolvation and melting). 1 H NMR of the same sample shows a peak at 8 = 3.17 ppm 
which integrates for 3 protons and corresponds to that expected for the methyl protons on 
methanol, thus confirming the presence of a 1:1 methanol solvate. Microanalysis was performed 
on a sample dried at l20°C overnight and gave the correct analysis for the desolvated salt. 
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Figure 2.8: Thermogravimetric and differential scanning calorimetric analysis of (R)-24 
A study of the cleavage of acetals using a sulfonic acid-based polystyrene cation exchange resin, 
Amberlyst-15, has been documented. 81 It is an attractive means of catalysing the hydrolysis 
because the work-up is exceedingly simple. When molecules with no basic functionality are 
hydrolysed, the resin is simply filtered off and the solvent removed to leave the crude product. 
With an amine such as 16, the product would be retained on the resin and elution with a basic 
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solvent would be required. The route is additionally attractive in the case of albuterol because 
the elution would allow isolation of (R)-albuterol as a free base as opposed to the acetate salt. 
Tlc showed the hydrolysis to be complete after stirring a solution of 16 in methanol/water, with 
the resin, at room temperature overnight. When acetone was tl;le reaction solvent (as used by 
Coppola81), decomposition was noted by tlc prior to completion of the reaction. Elution of the 
product from the resin was only partially achieved with 50% methanol/triethylamine or 
methanol/ammonia (prepared by passing a stream of ammonia through methanol for 20 min). 
Owing to the poor recoveries, this method was not pursued. Other strong cationic exchange 
resins with differing elution properties could be investigated, although epimerisation in the 
strongly acidic conditions may be problematic. 
2. 7 Racemisation Studies 
The economic viability of resolution procedures frequently depends on the ability to racemise 
and recycle the unwanted enantiomer. The initial racemisation route envisaged here was via 
oxidation of (S)-16 to the a-amino ketone 25 followed by hydride reduction to give (rac)-16 as 
depicted in Scheme 2.6. 
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Scheme 2.6: Envisaged racemisation of(S)-16 
The most common species used for the oxidation of secondary alcohols to ketones is hexavalent 







The presence of the acid-sensitive acetonide group on 16 meant that the use ofPCC-alumina was 
advisable. In this reagent, the acidic nature of PCC is diminished by adsorption onto alumina 
which acts as a buffer. In addition, work-up and removal of chromium-containing by-products is 
often difficult and alumina here acts as an adsorbent for the by-products of the reaction resulting 
in the work-up only requiring filtration and concentration. PCC-alumina was freshly prepared83 
and reacted with 16 in a ten-fold excess at room temperature. Tlc showed complete reaction to a 
single product after 5 hours. Filtration and evaporation of the solvent, however, delivered very 
little material. Attempts to recover additional material by washing the alumina with ethyl 
acetate/methanol mixtures failed. Similar difficulties with product recovery have been reported 
in the oxidation of P-amino alcohols and have been ascribed to the formation of strong chelates 
between the a-amino carbonyl compound and the chromium by-products of the reaction. 84 This 
may be avoided by protection of the amine as an amide, or via the more attractive option of 
using an oxidant containing no cationic metal species. 
Dimethyl sulfoxide (DMSO) may be used to oxidise alcohols to carbonyl compounds under mild 
conditions. It is used in conjunction with an activating species of which oxalyl chloride appears 
to be the most effective.85 These Swem oxidation conditions have been successfully applied to 
the oxidation of P-amino alcohols, although rapid polyrnerisation of the isolated product via 
intermolecular Schiff base formation is a problem in many cases. 86 The oxidation, using 
triethylamine as base, and work-up conditions as described for a successful isolation of an a-
amino carbonyl product86 were applied in the reaction with 16 but a complex mixture of 
products (by tlc) was obtained. In order to avoid the polyrnerisation associated with isolation of 
the amino-ketone, the Swem oxidation of a P-amino alcohol followed by in-situ reduction with a 
Grignard reagent has been described in an approach to the taxotere side chain. 87 This approach 
was followed by performing the oxidation of 16 in THF, followed by the addition of an excess of 
lithium aluminium hydride. Unfortunately, the recovery of material was poor and the product 
consisted of an inseparable mixture of compounds. 
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A more recently introduced reagent for the oxidation of primary and secondary alcohols under 







Tlc of the crude material from the Dess-Martin oxidation of 16 indicated the formation of a 
major product. The crude material was reduced with sodium borohydride without any further 
purification and the major product isolated by column chromatography. NMR evidence 
indicated the presence of alcohol 28, the formation of which is rationalised by the mechanism 
shown in Scheme 2.7. No further characterisation of the product was undertaken. 
-AcOH 
ojo. 
Scheme 2.7: Dess-Martin oxidation of 16 
\ 
OAc 
The possibility of using HCl catalysis, which proved problematic in the hydrolysis step, to the 
racemisation of albuterol was also briefly investigated. Acid catalysts have the potential of 
generating carbocations at chiral centres, provided suitable leaving groups as well as appropriate 
carbocationic stabilisation are available. In the case of albuterol, the benzylic carbocation would 
be stabilised by mesomeric release from the phenol moiety. The resulting intermediate would be 
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planar and reaction with an achiral reagent (H20) would thus result in a racemate. This is 
illustrated for albuterol in Scheme 2.8. 
-
Scheme 2.8: Acid catalysed racemisation of albuterol 
Hydrochloric acid-catalysed hydrolysis experiments were undertaken on (S)-16 recovered from 
the mother liquors of resolution. In order to monitor the progress of the racemisation, an aliquot 
of the reaction solution was withdrawn and the optical rotation measured. The reactions were 
also monitored by tlc. When methanol or ethanol was used as the reaction solvent, 
decomposition was detected prior to consumption of all the starting material. Heating at 50°C in 
a less polar solvent, tetrahydrofuran, resulted in complete conversion of 16 to albuterol, but the 
sample still showed significant optical rotation. When this completely hydrolysed sample was 
left to stir at room temperature overnight, no significant change to the optical rotation occurred 
and a small amount of decomposition was noted. When the solution was refluxed, a substantial 
decrease in optical rotation, which corresponded to -80% racemisation, was achieved. Complete 
racemisation was not, however, achieved without some decomposition. No further work was 
performed on this reaction, but other acids that are applied to the hydrolysis of ketals and the 
racemisation of alcohols, e.g. sulfuric or trifluoroacetic acid, should be investigated on this 
system. 
41 
CHAPTER3 DETERMINATION OF ABSOLUTE CONFIGURATION 
3.1 Introduction 
The absolute configuration of albuterol was assigned by Hartley and Middlemiss52 in 1971, on 
the basis of a negative Cotton effect in the circular dichroism spectrum of the (-)-enantiomer. 
This effect coincided with that shown by (R)-octopamine, which is also a phenylethanolamine, 
and the (-)-enantiomer of albuterol was thus assigned as having the (R)-configuration. From the 
outset of this project, a search of the Cambridge Structural Database89 revealed no 
crystallographic studies on homochiral albuterol or derivatives thereof. Although the absolute 
configurations of the enantiomers of 16 were later inferred from the optical rotation of 
compound 24 obtained on hydrolysis, the lack of structural work in this area led us to use 
crystallographic means in order to establish the absolute configuration of the enantiomer of 16 
precipitating in the n-salts with DOBT and DOTT. From the documented optical rotation of 24, 
(+)-16 was shown be the (S)-enantiomer and the enantiomers of 16 are illustrated with these 
inferred configurations in the following report describing the confirmation of this assignment. 
3.2 The DOBT and DOTT salts of Albuterol Acetonide 
Since the absolute stereochemistry of the stereogenic centres in these resolving agents is known, 
either stereocentre could serve as a reference for assigning the absolute configuration of 16 in a 
crystal structure solution of a diastereomeric salt. In addition, solution and inspection of the 
crystal structures of both the p and n diastereomeric salts would allow some rationalisation of the 
efficiency of the resolution.90 The n-salts, 20 and 21, which precipitated from resolution 
experiments were crystalline, but very insoluble in all but the most polar organic solvents. In 
spite of extensive efforts, no crystals of 20 or 21 with dimensions suitable for X-ray intensity 
data collection could be produced. Attempts to obtain crystalline material from the mother 
liquors of the resolution experiments by slow evaporation from various solvents resulted in oils. 
Solid material could only be obtained from the mother liquors when all solvent was removed 
under reduced pressure. The X-ray powder diffraction patterns of the DOBT salts of 16 were 
collected and are reproduced in Fig. 3.1. The sample obtained from the mother liquors, that is 
the p-salt, showed the expected contamination by the n-salt, but had no unique peaks in the 
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Figure 3.1: X-ray Powder Diffraction Patterns for the salts of 16 and (2R, 3R)-DOBT 
3.3 Structure determination of (+)-Aibuterol Acetonide, (+)-16 
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Calculation of the Flack absolute structure parameter91 indicates whether a refined absolute 
structure is correct or should be inverted. With MoKa radiation, as used here, the collection of 
high resolution data including Friedel opposites may allow the calculation of the Flack parameter 
to within a suitable standard deviation. Crystals suitable for the structure determination of ( + )-
16 isolated from initial resolution experiments were grown from acetone. 
Oscillation and Weissenberg photography revealed mmm Laue symmetry, indicating the 
orthorhombic system. The lack of any systematic absences among the general reflections on the 
Weissenberg photographs of the upper levels indicated the presence of a primitive lattice. There 
were no conditions on Okl, hOI and hkO reflections, but conditions on hOO and OkO (h = 2n and k 
= 2n respectively) were observed. From this information, the space group was tentatively 
assigned as P2 12121 (No. 19
74
) which is common amongst homochiral organic molecules. 
Further photographs were not taken to confirm this, but the third condition, 001 (l = 2n) was 
found on inspection of the intensity data, thus confirming the presence of this space group. All 
non-hydrogen atoms were located using direct methods and successful structure refinement, as 
described in Section 5.4.2, followed. 
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The value of the Flack parameter calculated with data collected at room temperature was 
inconclusive, so the data were recollected at -50°C and including higher e values. The final 
structure refinement was performed on these low temperature data. The high estimated standard 
deviation (1.6) of the Flack parameter in comparison to the parameter itself (1.8) after the final 
refmement calculation meant that no meaningful conclusions· on the absolute configuration of 
(+)-16 could be made. The structure solution did however confirm the presence of the 
isopropylidine ketal, as was inferred from 13C NMR data in Section 2.1. 
The structure of the molecule with the atomic numbering used is shown in Fig. 3.2. Details of 
the crystal data and structure refinement appear in Table 3.1. Fractional atomic co-ordinates, 
anisotropic displacement parameters, bond lengths, bond angles and torsion _angles appear in 
tables AI to A6 in Appendix 1 and structure factor data are included on diskette in Appendix 3. 
Figure 3.2: Molecular structure of(+)-16 showing atom labelling and intramolecular hydrogen 
bonding 
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Both inter- and intramolecular hydrogen bonding are present. In the intramolecular case, 




N9 .... 07 
2.844(2) A 
H9A ... 07 
2.387(2) A 
N9 -H9A ... 07 
111.1(1)0 
The structure is stabilised the single 0-R··· ··N intermolecular H-bonds with 
07 -H7 A 07 .... N9a H7 A .. . N9a 07 -H7 A ... N9a 
0.820(6) A 2.900(2) A 2.081(5) A 175.8(1)0 
where 'a' denotes symmetry related position x + Yl, -y + Yl, -z + 2. 
The intermolecular H-bonding scheme is illustrated by dotted lines in the stereoscopic packing 
diagram, Fig. 3.3. The albuterol acetonide molecules, propagated by a 2-fold screw axis, are 
located in spirals which run parallel to [100]. 
Figure 3.3: Stereoscopic view of crystal packing in (+)-16 
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a =5.958(1) A 
b =8.716(2) A 
c =30.481(3) A 
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0.28 and -0.26 e.A-3 
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The failed refinement of the Flack parameter is ascribed to the low scattering ability of the atoms 
present i.e. C, H, Nand 0 . The presence a heavier atom such as bromine in a crystal containing 
( + )-16 would increase the likelihood of successful absolute structure determination. Inclusion of 
p-bromophenol has aided the crystal structure determination of several steroid molecules.92•93 
Attempts to grow crystals from solutions containing various proportions of (+)-16 and p-
bromophenol were unsuccessful. The HBr salt of (+)-16 was prepared by the dropwise addition 
of dry ethanol to cold stirring phosphorus tribromide under nitrogen. The hydrogen bromide 
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generated was bubbled through a cold solution of (+)-16 in ether, resulting in the precipitation of 
the salt. Crystals of the salts could not be grown since attempts to isolate and redissolve the fine 
precipitate resulted in decomposition. 
3.4 Covalent Diastereomer Formation 
Since no success was achieved using the Flack approach to assign the absolute configuration, it 
was decided to prepare a covalent diastereomer by derivatising (-)-16 with a homochiral reagent 
of known absolute stereochemistry. The nucleophilic hydroxy and amino functional groups 
present in 16 were targeted as the positions at which to derivatise and a reagent bearing 
electrophilic reactivity was thus sought. Of the chiral pool materials, the chiral acids, which 
already bore the suitable carbonyl functionality, were the obvious starting point. 
3. 4.1 Mandelate derivatives of (-)-Albuterol Acetonide, (-)-16 
Condensation of (S)-Mandelic acid with (-)-16 could have resulted in the formation of either the 
mandelate ester 29 or the amide 30. The isolation of either of these products, or the diprotected 
version, as a crystalline compound was considered suitable for this study. 
The formation of an ester or amide using a carboxylic acid is not spontaneous and a coupling 
agent is usually required. The reagent of choice,94 dicyclohexylcarbodiimide, DCC, activates the 
acid by formation of an 0-acylurea. The urea is then displaced by the hydroxyl or amino 
nucleophile resulting in the formation of an ester or amide and dicyclohexylurea which 
precipitates from the reaction mixture. The reaction is, however, hampered by the spontaneous 
rearrangement of the 0-acylurea intermediate to an N-acylurea which does not undergo any 
further reaction. The use of an acylation catalyst eliminates this problem, with the preferred 
catalyst for ester formation being 4-(dimethylamino)-pyridine95 (DMAP) and 1-
hydroxybenzotriazole96 (HOBt) for amide formation. The DCCIHOBt conditions were applied 
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and a complex mixture of products was obtained. In order to avoid possible interference by the 
mandelic acid hydroxyl functionality, the reaction was repeated using (R)-0-acetylmandelic acid, 
but a similar result was obtained. Attempted chromatographic isolation of the major products 
resulted in decomposition on the silica. Difficulty in the coupling of N-alkylated amines has 
been reported97 and more exotic coupling agents98 are frequently required in order to achieve 
suitable reaction. 
The use of an activated carboxyl moiety such as an acid chloride negates the need for a coupling 
agent. It is, however, usually avoided in cases where the acid chloride contains an a-chiral 
centre which is tertiary, as in the case of mandelic acid, since abstraction of the tertiary carbon 
proton can lead to racemisation via an enol form. This is particularly true for mandelic acid in 
which the proton in question is also benzylic and thus has enhanced acidity. For this reason, the 
next derivatisation reagent chosen from the chiral pool was based on camphorsulfonic acid in 
which racemisation is not an issue. 
3 .4.2 Camphorsulfonyl derivatives of (-)-Albuterol Acetonide, (-)-16 
A chiral acid in which the chiral centre is remote from the acidic functionality can be used in an 
activated form without the aforementioned racernisation problem. (lR)-Camphor-1 0-sulfonyl 
chloride, 31, is an example of such a reagent and reacts with both alcohols and amines to give 
sulfonate esters and sulfonamides respectively. The reaction usually involves mixing a solution 
of the alcohol or amine in dichloromethane with camphorsulfonyl chloride in the presence of a 
base such as pyridine. Successful derivatisation of a secondary alcohol99 and a secondary 
amine 100 have been achieved under these mild conditions. 
S~CI 
31 
The procedure of Bartlett and Knox101 involving reaction of the sulfonic acid with phosphorus 
pentachloride was followed in order to prepare 31 . Minimal conversion of(-)-16 occurred under 
the sulfonylation conditions described above. After the addition of DMAP and 
dimethylformamide102 to the reaction mixture, a number of products were detected by tlc but 
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after work-up, largely unreacted 16 remained. Of the other material present, only the major 
product was isolated. Although the material showed most of the 1 H NMR resonances 
characteristic of 16, it was not the desired adduct and further characterisation was not 
undertaken. Derivatisation of a secondary alcohol with 31 has also been achieved using n-
butyllithium as the base103 and this approach was attempted. Again, 16 was not consumed, but 
in this reaction all of 31 was converted to one major product, with 1H NMR indicating that it 
contained two residues of 31. A plausible rationalisation for this is that deprotonation of the 
amino group of (-)-16 by n-butyllithium, resulted in an amide anion which itself behaved as a 
hindered base as opposed to a nucleophile in removing an acidic proton (a- to the carbonyl or 
sulfonyl groups) from 31. The resulting anion then reacted with an electrophilic site in another 
molecule of 31 to give the product. Although this reactivity is interesting, it did not achieve the 
objective of the study being undertaken and was not pursued. 
3.4.3 Mosher's Ester of(-)-Albuterol Acetonide, (-)-16 
Methoxytrifluoromethylphenylacetic acid (MTPA), or Mosher's acid (whose (R)-enantiomer is 
illustrated as 32 below) is one of the more popular chiral derivatising agents since the quaternary 
nature of its chiral centre suppresses the risk of racemisation described in Section 3.4.1. It is 
most frequently used for the determination of the enantiomeric purity of chiral alcohols and 
amines by the preparation of diastereomeric esters or amides which are then assayed using 
chromatographic or spectroscopic methods. 104 The preparative use of MTP A has been limited, 
possibly due to its high cost in comparison to that of other naturally occurring chiral acids. The 
absolute configuration of alcohols and amines, in which the heteroatom is attached to the 
stereocentre, has been determined using the 19F 105, and, more commonly, 1H NMR106 shifts of 




A literature method107 was followed to convert commercially available 32 to the more reactive 
acid chloride (R)-MTP ACl, which was purified by Kugelrohr distillation. This was reacted with 
(-)-16 in the presence of triethylamine and DMAP to produce a single product in high yield after 
49 
90 min at room temperature. The NMR spectra of the product were assigned by comparison 
with the spectra of 16 and by a further 2D NMR (HMQC) experiment. The product was 
assigned as the ester 33 as opposed to the amide on the basis of the significant downfield shift of 
the signal for 1-H (5.87 ppm) in the 1H NMR spectrum from a value of()= 4.80 ppm for 16. 
This is substantiated by a similar comparison of the signals for C-1 in the 13C spectrum in which 
the shift was from 72.0 to 79.0 ppm. If an amide had been formed, a degree of deshielding of 
the quaternary tertiary butyl carbon by the carbonyl would have been expected but the shift of 
this atom remained unchanged at 50.3 ppm. The infrared spectrum for 33 displayed a carbonyl 
absorption band at 1748 cm-1 which corresponds to that expected for an ester whilst that for an 
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Scheme 3.1: Derivatisation of(-)-16 with (R)-MTPACl 
The isolation of 33 as an oil was disappointing in that no X-ray structural studies could be 
carried out. The chemoselectivity demonstrated in the above reaction was again ascribed to the 
hardness of the carboxylic acid chloride electrophile which preferred to react with the harder 
oxygen nucleophile. Steric crowding of the nitrogen nucleophile by the t-butyl substituent could 
also have played a role. It was a fortuitous result in that 1 H NMR could be used to gain more 
insight into the absolute stereochemistry of the parent alcohol. Mosher analysis involves the 
preparation of diastereomeric Mosher esters and comparison of the chemical shifts of proton 
resonances from the groups attached to the asymmetric carbon ( C-1) in each of the esters. A 
correlation between the chemical shifts and the conformation of the ester is made in order to 
assign the absolute configuration at the unknown chiral centre. 
The analogous derivatisation of (rac)-16 was performed and the proton NMR spectrum of the 
resulting mixture of diastereomers recorded. By comparison of the latter with the spectrum of 
33, the signals of the diastereomer arising from (+)-16, 34, were extracted and the chemical 
shifts of the two diastereomers examined. These chemical shift data are presented in Table 3.2. 
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Table 3.2: 1H Chemical shift data for the (R)-Mosher esters of(+)- and (-)-16 
34 33 ~8 = 834-833 
Proton 8 (ppm) 8 (ppm) (ppm) 
t-Bu 0.98 1.06 -0.08 
2x2'-CH3 1.52 1.53 -0.01 
2-HA 2.75 2.83 -0.08 
2-HB 2.99 3.00 -0.01 
2"-0CH3 3.43 3.54 -0.11 
4'-HA 4.78 4.72 +0.06 
4'-HB 4.84 4.79 +0.05 
1-H 5.92 5.87 +0.05 
8'-H 6.79 6.75 +0.04 
5'-H 6.99 6.83 +0.16 
7'-H 7.18 7.07 +0.11 
other Ar-H 7.2-7.5 7.2-7.5 
As illustrated in Fig. 3.4(a), 33 can thus be considered as having two substituents on the chiral 
carbon: L1 in which protons are deshielded relative to 34, and L2 in which they are relatively 
shielded. The preferred conformation106•108 of33 in which the C-1 - H bond is gauche to the 0-
C-1" bond, the C-1 - 0 bond is trans to C-1"- C-2" and the C-2"- CF3 and C=O bonds are 
almost syn periplanar is shown in the sawhorse diagram Fig. 3.4(b) and the Newman projection 
3.4(c) along C-1"- C-2" and C-1- 0. This information is related to the absolute configuration of 
the molecule with the aid of a Newman projection along C-1 - C-2" (Fig. 3.4(d)). 
Figure 3.4: Stereochemical projections ofthe preferred conformation of33 
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Fig. 3 .4( c) indicates that, with the absolute configuration and conformation shown, the protons 
on L2 in 33 should be subjected to aromatic shielding by the MTP A phenyl substituent and thus 
found upfield relative to the equivalent protons on 34 (the Newman projection for 34 would have 
the positions of L1 and L2 reversed). Similarly, the protons on L1 should be found further 
downfield than those of 34 due to the shielding of those on 34 by the MTPA phenyl moiety. 
Both of these trends are followed by the experimental NMR data, thus providing additional 
evidence that the absolute configuration of (-)-16 is (R)-, as was concluded from the hydrolysis 
studies. In addition, the NMR data show the MTP A methoxy protons to be further downfield in 
33 than in 34. L2 is aromatic in nature and will shield the methoxy protons when the two are 
juxtaposed, which occurs when the absolute configuration at C-1 is (S)- as in 34. 
Some unexpected 1H NMR results for the Mosher esters of alcohols have been reported109•110. A 
recent computational study111 shows that, contrary to the conformational model applied above, 
three low energy conformations of the esters may exist, each of which has a different shielding 
effect on either L1 or L2 (Fig. 3.5). 
(c) 
shielding on L2 deshielding on L2 deshielding on L 1 
Figure 3.5: Low energy conformers of (R)-MTPA esters 
The small ~() values can be explained by the mutual cancellation of the aromatic anisotropic 
effects on L2 in (a) and (b), and the fact that the magnitude of deshielding as provided by (c) is 
usually smaller than shielding. The relative populations of each conformer, as well as the degree 
of shielding or deshielding contributed by each would have to be calculated for the ester 
concerned before the absolute configuration determined in this manner could be quoted with 
certainty. It was shown in the same study that, in the equivalent methoxyphenylacetic acid 
esters, one conformer is more populated and thus, if the racemisation problems are overcome, a 
more reliable determination of absolute configuration is provided. The equivalent modelling 
studies on Mosher amides112 show rotamer (a) to be lowest in energy thus also allowing reliable 
predictions. 
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3.4.4 Phenylethylurea derivatives of(+)-and (-)-Albuterol Acetonide 
In the light of the aforementioned doubts shed on the Mosher analysis, structural evidence for the 
assigned absolute configurations was still sought and this led to the preparation of (R)-
phenylethylamine derivatives of 16. Alkyl isocyanates, R-N=C=O, are reactive species which 
derivatise alcohols and amines under mild conditions to give carbamate esters (or urethanes) and 
ureas respectively. (S)-phenylethyl isocyanate has been used to form a urethane on a marine 
epoxyquinol to allow X-ray crystallographic determination of the absolute stereochemistry of the 
molecule. 113 Isocyanates are usually prepared by reaction of the parent amine with phosgene 
(COCb). 114 The toxicity of phosgene, however, makes this methodology unattractive and 
triphosgene (ChCOC02CCh) has become a popular commercial altemative. 115 The preparation 
of asymmetrically substituted ureas in a one-pot method utilising triphosgene and two amino 
acid esters has been reported. 116 This procedure was applied to the formation of (R)-phenylethyl 
isocyanate 35 from (R)-phenylethylarnine, followed by in-situ derivatisation of (-)-16. Tlc 
showed the formation of a major product with a single impurity of similar polarity. The impurity 
could not be removed by chromatography on silica gel, but a 1 H NMR spectrum of the impure 
oil indicated the formation of the desired urea or urethane. The reaction was repeated using 
(rac)-16 as substrate and two products, assumed to be the two diastereomers, were obtained (as 
well as the earlier impurity). The diastereomer arising from (+)-16, 36, was isolated, crystallised 
and characterised. Although the chemoselectivity of 16 was expected to be as for Mosher ester 
formation, i.e. to give a carbamate ester via attack at the benzylic hydroxyl group, a comparison 
of relevant chemical shifts (Table 3.3) did not support this outcome. 
Table 3.3: Comparison of selected 1H and 13C NMR chemical shifts of 16 and 36 
Atom 16 o(ppm) 36 o(ppm) 
t-Bu C(CH3)3 1.07 1.40 
2-HA 2.56 3.23 
2-Hs 2.80 3.44 
1-H 4.50 4.76 
t-Bu C(G-I3)3 29.1 29.1 
C-2 50.3 54.4 
t-Bu C(CH3)3 50.3 55.9 
C-1 72.0 76.7 
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The unexpected formation of the (R)-phenylethylurea of (+)-16, (Scheme 3.2) was revealed on 
crystal structure solution (discussed in Section 3.4.5). The carbonyl carbon in the reacting 
isocyanate moiety is a softer electrophilic centre than that in an acid chloride. It is thus 
suggested that the softer amino nucleophile was preferred to the hydroxyl nucleophile in this 
reaction. Although 36 is a urea, it has been named and numbered as a derivative of 16 for the 









Scheme 3.2: Urea formation with in-situ generation of(R)-phenylethyl isocyanate 
As (-)-16 gave rise to the desired (R)-albuterol on hydrolysis, the preferred diastereomer for 
crystal structure determination was that synthesised from this enantiomer, i.e. 37. Owing to the 
aforementioned experimental problems, the derivatisation of (-)-16 was performed in two steps. 
The frrst step in the one-pot method was performed and this was followed by a fast, cold 
aqueous work-up procedure117 to isolate 35 which was purified by Kugelrohr distillation. The 
infra-red spectrum showed a strong band with Vmax 2250 cm-1 corresponding to isocyanate 
formation. The reaction with (-)-16 proceeded as expected and the (R)-phenylethylurea of(-)-16, 
i.e. compound 37, was isolated. Although full characterisation of 37 was carried out, no crystals 
of this material suitable for X-ray analysis could be produced. The crystal structure 
determination on 36, which provided the stereochemical information sought equally well, was 
thus undertaken. 
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3.4.5 Crystal structure of (R)-Phenylethylurea of (+)-Albuterol Acetonide, 36 
The oscillation, and de Jong-Bouman photographs revealed the presence of mmm Laue 
symmetry, thus indicating the orthorhombic crystal system. Comparison of upper layers 
revealed no systematic absences in the general reflections and the lattice was thus established to 
be primitive. There were no conditions on Okl, hOI and hkO. However conditions of h = 2n, k = 
2n and I = 2n for observed reflections on bOO, OkO and 001 respectively led to the deduction of 
P212121 space group symmetry. 
The structure was solved by direct methods and successfully refmed, giving a fmal R value of 
0.0396. The data for the collection and refinement are given in Table 3.4 and fractional atomic 
co-ordinates, anisotropic displacement parameters, bond lengths, bond angles and torsion angles 
have been reproduced in tables B 1 to B6 in Appendix 2, and structure factor data are included on 
diskette in Appendix 3. 
The relative stereochemistry of the chiral centres (labelled as C7 and C22 respectively) is clearly 
defined in the molecular structure (Fig. 3.6) and, since the absolute configuration at C22 was 
known to be (R)-, that at C7 was unambiguously assigned as (S)-. Since this centre originates 
from ( + )-16, the assignment made on the basis of the optical rotation of the hydrolysis products 
was confirmed. 
Figure 3.6: Molecular structure ofthe (R)-phenylethylurea of(+)-16 
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The intramolecular hydrogen bond illustrated in Fig 3.6 has the following parameters: 
N21 -H21 N21 .... 07 H21 ... 07 N21 -H21 ... 07 
0.860(2) A 2.867(2) A 2.079(2) A 152.1(1)0 
Single intermolecular H-bonds between a hydroxyl donor and carbonyl acceptor were found: 
07 -H7A 07 .... 020a H7A ... 020a 07 -H7A ... 020a 
0.820(13) A 2.728(1) A 1.950(12) A 158.0(1.1)0 
where 'a' denotes symmetry related position x + 1, y, z. 
This results in an infinite ribbon of hydrogen bonding running through the structure parallel to 
(100], as can be seen on the stereoscopic packing diagram below. 
Figure 3. 7: Stereoscopic packing diagram of 36 
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The primary objective of this work was to produce (R)-albuterol using crystallisation techniques. 
This has been achieved by performing a low cost, high yielding protection of (rae )-albuterol and 
resolving the resulting acetonide via diastereomeric salt formation with (2S,3S)-di-O-
benzoyltartaric acid and (2S,3S)-di-O-toluoyltartaric acid. (R)-Albuterol was obtained as its 
acetate salt in high yield and optical purity by acid hydrolysis of the resolved acetonide 
derivative. The efficiency of the resolution step as well as the simplicity of the protection and 
deprotection steps make this an attractive industrial alternative to the present resolution methods 
in which, although albuterol precursors are resolved, the protection and deprotection steps 
required are less amenable to large scale syntheses. Existing chiral hplc and 1 H NMR methods 
were adapted, optimised and applied to the determination of optical purity of the resolved 
intermediate to allow in-process monitoring. In order for this process to be truly competitive 
industrially, further work on the racemisation of the intermediate, towards obtaining a 100% 
theoretical yield of (R)-albuterol, is required. In addition, the application of ion exchange 
methodology to the isolation of (R)-albuterol as a free base should be investigated. Construction 
and comparison of solubility phase diagrams for the diastereomeric salt pairs as well as the final 
product is also suggested in order to determine the optimal stage in the production process at 
which to apply recrystallisation to increase optical and chemical purity. 
The successful structure elucidation of the (R)-phenylethylurea derivative of (S)-albuterol 
acetonide is the first structural evidence available for confirmation of the assignment of the 
absolute configuration of the enantiomers of albuterol first proposed on the basis of circular 
dichroism studies. This was further corroborated by the preparation and 1 H NMR analysis of the 
(R)-Mosher esters of the enantiomers of albuterol acetonide. The synthetic work involved in 
producing the various diastereomeric derivatives of the acetonide has also provided some insight 




Melting points were measured using a Reichert-Jung Thermovar hot-stage microscope and are 
uncorrected. Optical rotations were measured on a Perkin-Elmer 141 polarimeter. Infrared 
spectra were recorded using a Perkin-Elmer Paragon 1000 FT-IR spectrometer over the range 
4000-600 cm-1• Microanalyses were determined using a Fisons EA 1108 CHNS-0 instrument. 
Mass spectra were recorded on a VG micromass 16F spectrometer operating at 70 eV with an 
accelerating voltage of 4kV. Accurate masses were determined on a VG-70E spectrometer at the 
Cape Technikon. 1H-NMR spectra were recorded on a Varian VXR-200 (200MHz) or a Varian 
Unity Spectrometer ( 400MHz). 13C-NMR spectra were recorded on the same instruments at 50 
or 1 OOMHz. The relevant solvent peak (CHCh or DMSO) was used as an internal standard in 
each case. Thermal gravimetric analysis and differential scanning calorimetry were performed 
on a Perkin Elmer PC7 Series thermal analysis system. High performance liquid 
chromatography was performed on a Hewlett Packard 1 090 system with a diode array detection 
and a Hewlett Packard 3393A integrator. 
Thin layer chromatography was performed on aluminium backed silica gel 60 F254 plates. The 
plates were visualised under ultraviolet light and by spraying with eerie ammonium sulphate in 8 
mol.dm-3 sulfuric acid and baking at 200°C. Column chromatography was conducted with 
Merck Kieselgel 60, 70-230 mesh. 
Acetone was distilled from Drierite (anhydrous CaS04) and stored over 4A molecular sieves. 
Dichloromethane was freshly distilled from P20 5 prior to use. Solvents used for hplc were BDH 
HiperSolv grade. Albuterol was supplied by South African Druggists, Port Elizabeth, South 
Africa. The major optically active reagents used were purchased as follows: 
(2S,3S)-Di-O-benzoyltartaric acid (99%) Merck 
(2S,3S)-Di-O-benzoyltartaric acid monohydrate (99%) 
(2S,3S)-Di-O-toluoyltartaric acid (97%) 











To a stirred slurry of albuterol (1.036 g, 4.3 mmol) in CH2Cb (10 cm
3) at 0°C was added 2,2-
dimethoxypropane (1.6 cm3, 1.37g, 13.1 mmol) and BF]"OEt2 (1.6 cm3, 1.85g, 13.0 mmol). The 
solution was stirred at room temperature for 12 h after which time the reaction was quenched 
with aqueous Na2C03. The mixture was extracted into CH2Cb, dried (MgS04) and the solvent 
removed under reduced pressure to give an oily residue (1.32 g). The residue was 
chromatographed on silica gel with methanoVethyl acetate (30/70) to furnish 19 (790 mg, 3.0 
mmol, 68%), mp 109-110°C (acetone); Found C, 67.4; H, 9.8; N, 5.2; C15H25N03 requires C, 
67.4; H, 9.4; N, 5.2%; Vmax (CHCh)/cm"1 3374 (0-H), 2960 (-CH2-), 2832 (-OCH3), 1501 
(aromatic C-C), 1365 (C-N), 1232 (phenolic C-0), 1097 (dialkyl C-0); 8H (200MHz, CDCh) 
1.08 (9H, s, t-Bu), 2.56 (1H, dd, J 11.5 and 3.7 Hz, 2-HA), 2.80 (1H, dd, J 11.5 and 9.3 Hz, 2-
Hs), 3.16 (3H, s, -OCH3), 3.44 (3H, s, -OCH3), 4.19 (lH, dd, J9.3 and 3.7 Hz, 1-H), 4.60 (1H, 
br s, NH), 4.61 (2H, s, 3'-CH20CH3), 6.83 (1H, d, J 8.3 Hz, 5'-H), 7.02 (1H, d, J 1.7Hz, 2'-H), 
7.12 (1H, dd, J 8.3 and 1.7 Hz, 6'-H); 8c (50MHz, CDCh) 28.8 (t-Bu -CH3), 49.8 (C-2), 50.1 (t-
Bu -C(CH3)3), 56.4 (O-CH3), 58.3 (O-CH3), 73.1 (C-1), 83.2 (3'-CH2-), 116.2 (C-5'), 122.9 (C-
3'), 126.7 (C-2'), 127.7 (C-5'), 131.4 (C-1'), 155.8 (C-4'), (Found M+, 267, C15H25N03 requires 
M, 267). 
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(a) BF3·0Eh procedure 
Freshly distilled BF3·0Et2 (2.7 cm3, 3.1 g, 22.0 mmol) was added dropwise to a stirred mixture 
of albuterol (2.39 g, 10.0 mmol) in dry acetone (50 cm3) under nitrogen at 0°C. The solution 
was stirred at 0°C for 60 min after which it was slowly poured into 50 cm3 cold aqueous 
Na2C03. The excess acetone was removed under reduced pressure and the mixture extracted 
into ethyl acetate. The combined organic phases were dried (MgS04) and the solvent removed 
in vacuo to give a crystalline crude product (2. 70 g). Column chromatography on silica gel with 
ethyl acetate/ petroleum ether/triethylamine (50/45/5) afforded 16 as a colourless crystalline 
product (2.67 g, 9.6 mmol, 96%), mp 91-92°C (acetone); Found C, 68.9; H, 9.3; N, 5.0; 
ci6H2sN03 requires c, 68.8, H, 9.0; N, 5.0%; Vmax (CHCh)/cm-1 3402 (0-H), 2969 (-CHr), 
1501 (aromatic C-C), 1118 (C-0); 8H (400MHz, CDCh) 1.07 (9H, s, t-Bu), 1.505 (3H, s, 2'-
CH3), 1.510 (3H, s, 2'-CHJ), 2.56 (1H, dd, J 11.7 and 9.0 Hz, 2-HA), 2.75 (2H, br s, OH/NH), 
2.80 (1H, dd, J 11.7 and 3.5 Hz, 2-Hs), 4.50 (1H, dd, J 9.0 and 3.5 Hz, 1-H), 4.81 (2H, s, 4'-H2), 
6.76 (1H, d, J 8.3 Hz, 8'-H), 6.99 (1H, d, J 1.6 Hz, 5'-H), 7.11 (1H, dd, J 8.3 and 1.6 Hz, 7'-H); 
8c (lOOMHz, CDCh) 24.6 and 24.8 (2'-CHJ) 29.1 (t-Bu -CH3), 50.3 (C-2), 50.3 (t-Bu -C(CH3)3), 
61.0 (C-4'), 72.0 (C-1), 99.5 (C-2'), 116.8 (C-8'), 119.2 (C-4'a), 122.0 (C-5'), 125.7 (C-7'), 134.9 
(C-6'), 150.5 (C-8'a), (Found M+, 279, C16H2sN03 requires M, 279). 
(b) CuSOJH2S04 procedure: 
Acetone (50 cm3) was added to a flask containing albuterol (2.39 g, 10.0 mmol) and anhydrous 
copper sulphate (1.65 g, 10.0 mmol) and the resulting mixture cooled to 0°C under nitrogen. 
Concentrated sulfuric acid (1.3 cm3, 22.0 mmol) was added dropwise and the solution stirred for 
60 min at 0°C. The work-up procedure as used above resulted in 2.70 g crude material which 
was purified in an identical manner to yield crystalline 2 (2.65 g, 9.5 mmol, 95%). 








(S)-( + )-Binaphthylphosphoric acid 
( 1 R)-(-)-Camphor-1 0-sulfonic acid 
(2R,3R)-(-)-Di-0-benzoyltartaric 
(S)-(-)-Malic acid 
(2R,3R)-( +)-Tartaric acid 







0.2 mmol of each of the relevant acid and base was weighed into a glass vial. 1 cm3 of the 
required solvent was added and the solution heated sufficiently to allow dissolution of all solids 
(not achieved in all cases). The vials were stoppered and left to stand at room temperature. 
Where no precipitate was observed after 24 h, the lids were removed to allow slow evaporation. 
In each case either an oil, paste or crystalline material was obtained. Where solid crystalline 
material was obtained, the melting point was compared to that of the parent acid and base to 
indicate formation of a new species. 
62 
(2S,3S)-Di-O-benzoyl tartrate salt of (R)-16 20 
OH ~/H .t}o -~oc·kOc~-0 
'C(CH3)3 
3 ~ # 
2 
4" 5" 
To a refluxing solution of (rac)-16 (1.90 g, 6.8 mmol) in methanol (15 cm3) was added a hot 
solution of (2S,3S)-di-O-benzoyltartaric acid monohydrate (1.32 g, 3.5 mmol) in methanol (10 
em\ Heating was discontinued and the solution stirred until a solid cake of precipitate formed. 
A further 20 cm3 methanol was added and the solution refluxed for a further 10 min whereafter it 
was stirred at room temperature for 2 h. The resulting precipitate was isolated by filtration, 
washed with ethyl acetate and dried under vacuum to yield the diastereomeric salt 20 (1.10 g, 
1.20 mmol, 71% yield as a single enantiomer, 93.9% de*). A portion of this salt (0.80 g, 0.87 
mmol) was further purified by redissolving it in boiling methanol (70 cm3) followed by stirring 
at 0°C overnight. The salt was isolated and dried as above (0.50 g, 0.55 mmol, 63% for this 
step, 45% overall yield as a single enantiomer, >99.5% de*), mp 188-190°C (methanol); [a] 0 
+24.6° (c 0.19 methanol); Found C, 65.5; H, 7.1; N, 3.0; C5oH64N20 14 requires C, 65 .5, H, 7.0; 
N, 3.1 %; Ymax (KBr)/cm-1 3411 (0-H), 2900-2400 (tt -H), 1723 (C=O ester), 1641 (C=O 
carboxylate (s)), 1504 (C=O carboxylate (as)), 1118 (2° C-0); OH (400MHz, DMSO-d6) 1.13 
(9H, s, t-Bu), 1.44 (6H, s, 2x2'-CHJ), 2.68 (1H, dd, J 11.9 and 10.3 Hz, 2-HA), 2.90 (1H, dd, J 
11.9 and 2.4 Hz, 2-Hs), 3.36 (2H, br s, NH), 4.72 (lH, dd, J 10.3 and 2.4 Hz, 1-H), 4.76 (2H, s, 
4'-H2), 5.66 (1H, s, DOBT 2-H), 6.71 (1H, d, J 8.4 Hz, 8'-H), 7.00 (1H, d, J 1.9 Hz, 5'-H), 7.10 
(1 H, dd, J 8.4 and 1.9 Hz, 7'-H); 7.50 (1H, m, DOBT 3"-H and 5"-H), 7.63 (lH, m, DOBT 4"-H), 
8.00 (1H, dd, J 7.8 and 1.4 Hz, DOBT 2"-H and 6"-H); oc (100MHz, DMSO-d6) 24.4 and 24.5 
(2'-CHJ) 25.1 (t-Bu -CH3), 48.1 (C-2), 54.7 (t-Bu -C(CH3)3), 60.0 (C-4'), 68.2 (C-1), 74.9 
(DOBT C-2), 99.1 (C-2'), 116.0 (C-8'), 119.0 (C-4'a), 122.4 (C-5'), 125.5 (C-7'), 128.3 (DOBT 
C-3" and C-5"), 129.1 (DOBT C-2" and C-6"), 130.6 (DOBT C-1 "), 132.8 (DOBT C-4"), 134.1 
(C-6'), 149.9 (C-8'a), 165.1 (DOBT C-1'), 170.2 (DOBT C-1). 
* Note: Diastereomeric excesses of the above salt was determined by liberation of 16 from the 
salt as outlined below and subsequent chiral hplc determination (described in 5.3.3) of the 
enantiomeric excess in the crude extract obtained. 
63 
(2S,3S)-Di-O-toluoyl tartrate salt of (R)-16 21 
(rac)-16 (7.50 g, 26.9 mmol) was dissolved in methanol (60 cm3)and heated to reflux. A hot 
solution of(2S,3S)-di-0-toluoyltartaric acid (5.30 g, 3.7 mmol) in methanol (40 cm3) was slowly 
added to the refluxing solution. Precipitation started during the addition and a solid cake formed 
on complete addition of the resolving agent. A further 100 cm3 methanol was added and the 
resulting slurry refluxed for 10 min followed by stirring at room temperature for 2 h. The 
precipitate was filtered off, washed with ethyl acetate and dried under vacuum to yield 21 (5.75 
g, 6.1 mmol, 91% as a single enantiomer, 90.0% de*). This salt (5.25 g, 5.6 mmol) was added to 
boiling methanol ( 450 cm3) and stirred at ooc overnight. The solid material was again isolated 
by filtration, washed with ethyl acetate and vacuum dried ( 4.19 g, 4.4 mmol; 80% for this step, 
73% overall yield as a single enantiomer, 95.2% de*), mp 191-192°C (methanol); [a]0 +38.5° (c 
0.15 methanol); Found C, 65.8; H, 7.3; N, 2.9; Cs2H6sN2014 requires C, 66.1, H, 7.2; N, 3.0%; 
Vmax (K.Br)/cm-1 3409 (0-H), 2900-2400 {W-H), 1721 (C=O ester), 1641 (C=O carboxylate (s)), 
1503 (C=O carboxylate (as)), 1123 (2° C-0); 8H (400MHz, DMSO-d6) 1.14 (9H, s, t-Bu), 1.45 
(6H, s, 2x2'-CHJ), 2.37 (3H, s, DOTT 4"-CHJ), 2.67 (IH, dd, J 12.0 and 10.4 Hz, 2-HA), 2.89 
(1H, dd, J 12.0 and 2.2 Hz, 2-Hs), 3.35 (2H, br s, NH), 4.71 (1H, dd, J 10.4 and 2.2 Hz, 1-H), 
4.76 (2H, s, 4'-H2), 5.61 (lH, s, DOTT 2-H), 6.71 (1H, d, J 8.4 Hz, 8'-H), 6.99 (1H, d, J2.0 Hz, 
5'-H), 7.09 (1H, dd, J 8.4 and 2.0 Hz, 7'-H); 7.29 (1H, d, J 8.2 Hz, DOTT 3"-H and 5"-H), 7.87 
(1H, d, J 8.2 Hz, DOTT 2"-H and 6"-H); 8c (100MHz, DMSO-d6) 21.1 (DOTT 4"-CH3), 24.4 
and 24.5 (2'-CHJ) 25.0 (t-Bu -CH3), 48.1 (C-2), 54.7 (t-Bu -C(CH3)3), 60.0 (C-4'), 68.2 (C-1 ), 
74.8 (DOTT C-2), 99.1 (C-2'), 116.0 (C-8'), 118.9 (C-4'a), 122.4 (C-5'), 125.5 (C-7'), 128.0 
(DOTT C-1 "), 128.8 (DOTT C-3" and C-5"), 129.2 (DOTT C-2" and C-6"), 134,1 (C-6'), 142.9 
(DOTT C-4"), 149.9 (C-8'a), 165.2 (DOTT C-1'), 170.6 (DOTT C-1). 
* Note: Diastereomeric excess of 21 was determined as for 20. 
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To a vigorously stirring mixture of ethyl acetate (200 cm3) and aqueous Na2C03 (200 cm3) was 
added 21 ( 4.19 g, 4.4 mmol). Stirring was continued until no solid material remained. The 
organic layer was removed and the aqueous phase extracted twice with equal volumes of ethyl 
acetate. The combined organic phases were dried (MgS04) and the solvent removed under 
reduced pressure to yield a colourless crystalline solid (2.43 g, 8.7 mmol, 98%). 












mp 102-103°C (acetone); [a]0 -18.9° (c 1.5 methanol); Found C, 68.5; H, 9.6; N, 5.1; 
C16H2sN03 requires C, 68.8; H, 9.0; N, 5.0%; DH (400MHz, CDCl3) 1.11 (9H, s, t-Bu), 1.53 (3H, 
s, 2'-CH3), 1.54 (3H, s, 2'-CHJ), 2.56 (1H, dd, J 11 .7 and 9.1 Hz, 2-HA), 2.12 (2H, br s, OH/NH), 
2.87 (1H, dd, J 11.7 and 3.5 Hz, 2-Hs), 4.51 (1H, dd, J9.0 and 3.5 Hz, 1-H), 4.84 (2H, s, 4'-H2) , 
6.79 (1H, d, J 8.4 Hz, 8'-H), 7.01 (1H, d, J 1.5 Hz, 5'-H), 7.13 (1H, dd, J 8.4 and 1.5 Hz, 7'-H). 
Liberation of (R)-16 from the analogous Di-0-benzoyltartrate salt was performed in an identical 
fashion and the same % yield was achieved. 
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(2S,3S)-Di-0-benzoyltartaric acid recovery 
The pH of the basic aqueous phase remaining after extraction of (R)-16 from the salt 20 (2.00 g, 
2.2 mmol) was adjusted to about 4 with 1M HCl. The resulting solution was extracted three 
times with equal volumes of ethyl acetate. The combined organic phases were dried (MgS04) 
and the solvent removed in vacuo to produce a clear oil which solidified during vacuum drying 
(0.76 g, 2.1 mmol, 97%), [a] 0 +114° (c 1.9 methanol)(lit. +116°). 
(2S,3S)-Di-0-toluoyltartaric acid recovery 
After liberation of (R)-16 from its di-0-toluoyltartrate salt, (4.19 g, 4.4 mmol) the remaining 
aqueous phase was acidified, extracted and dried as above. On addition of toluene to the oil and 
subsequent removal under reduced pressure, a crystalline solid was obtained (1.70 g, 4.4 mmol, 
99%), [a]0 +135° (c 1 methanol) (lit. =138°). 
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(R)-Albuterol acetate monomethanolate (R)-24 
OH H H -
I / · CH3COO · CH30H 
N+ 
'C(CH3)3 HO 
Glacial acetic acid (0.4 cm3, 7.2 mmol)was added to a mixture of (R)-16 (90 mg, 0.32 mmol, 
95.5% ee*) in H20 (0.4 cm
3, 0.4 g, 22 mmol). The resulting solution was stirred at 60°C for 5h. 
The solvents were removed by vacuum distillation to leave a colourless tacky oil which was 
taken up in methanol and chilled. Ethyl acetate was added to this solution resulting in the 
precipitation of (R)-24 (98 mg, 0.30 mmol, 92%, 97.0% ee*), mp 143-144°C (methanol/ethyl 
acetate) (lit. 144.3°C); 8H (400MHz, DMSO) 1.15 (9H, s, t-Bu), 1.82 (3H, s, CH3COO-), 2.66 
(1H, dd, J 11.7 and 9.6 Hz, 2-HA), 2.75 (1H, dd, J 11.7 and 3.4 Hz, 2-Hs), 3.17 (3H, s, CH30H), 
4.48 (2H, s, 3'-CH20H), 4.60 (lH, dd, J9.6 and 3.4 Hz, 1-H), 5.22 (3H, br s, OH!NH), 6.73 (1H, 
d, J 8.1 Hz, 5'-H), 7.03 (lH, dd, J 8.1 and 1.9 Hz, 6'-H), 7.27 (lH, d, J 1.9 Hz, 2'-H), 8c 
(200MHz, DMSO) 23.5 (CH3COO-), 27.6 (t-Bu -CH3), 49.2 (CH30H), 50.2 (C-2), 53.1 ((t-Bu-
C(CH3)3), 59.0 (3'-CH20H), 71.1 (C-1), 114.8 (C-5'), 125.5 (C-6'), 125.7 (C-2'), 128.7 (C-3'), 
134.1 (C-1'), 154.1 (C-4'), 174.5 (CH3COO} Since desolvation ofthe salt occurred on drying at 
room temperature, the following analyses were performed on the fully desolvated material: [a]0 
-37.9° (c 0.5 methanol); Found C, 60.4; H, 8.6; N, 4.7; C1sH2sNOs requires C, 60.2, H, 8.4; N, 
4.7%. 
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To a solution of(R)-16 (280 mg, 1.0 mmol) in dichloromethane (5 cm3) at room temperature and 
under nitrogen was added N,N-dimethylaminopyridine (127 mg, 1.0 mmol), triethylamine (0.7 
cm3, 511 mg, 5.0 mmol), and (R)-(2-methoxy-2-trifluoromethyl) phenylacetyl chloride (0.23 
cm3, 311 mg, 1.2 mmol). The resulting yellow solution was stirred for 90 min followed by 
quenching with aqueous Na2C03. The mixture was extracted into dichloromethane and the 
combined organic phases dried (MgS04) and the solvent removed under reduced pressure giving 
an oil (500 mg) which was adsorbed onto silica and chromatographed using ethyl 
acetate/petroleum ether (20/80) as eluent to give the product 33 as an oil (416 mg, 0.8 mmol, 
84%), [a]o 1.7° (c 1.5 methanol); Vmax (CHCh)/cm-1 1748 (C=O ester), bH (400MHz, CDCh) 
1.06 (9H, s, t-Bu), 1.53 (6H, s, 2x2'-CH3), 2.83 (1H, dd, J 12.3 and 4.1 Hz, 2-HA), 3.01 (IH, dd, 
J 12.3 and 9.3 Hz, 2-Hs), 3.55 (3H, s, 2"-0CHJ), 4.72 (1H, d, J 15.0Hz, 4'-HA), 4.79 (1H, d, J 
15.0Hz, 4'-Hs), 5.87 (IH, dd, J9 .3 and 4.1 Hz, 1-H), 6.75 (1H, d, J 8.5 Hz, 8'-H), 6.83 (1H, d, J 
2.2 Hz, 5'-H), 7.07 (IH, dd, J 8.5 and 2.2 Hz, 7'-H); 7.2-7.4 (3H, m, 3"'-H, 4"'-H, 5"'-H ), 7.46 
(2H, d, J 7.4 Hz, 2"'-H, 6"'-H); be (100MHz, CDCh) 24.6 and 24.7 (2'-CHJ) 28.8 (t-Bu -CH3), 
47.8 (C-2), 50.3 (t-Bu -C(CH3)3), 55.5 (2"-0CHJ), 60.7 (C-4'), 79.0 (C-1), 84.6 (q, 2"-CF3), 99.6 
(C-2'), 117.0 (C-8'), 119.2 (C-4'a), 123.3 (C-5'), 126.6 (C-7'), 127.5 (C-2"', C-6"')128.2 (C-3"', C-
5"'), 129.4 (C-4"'), 129.6 (C-1"'), 132.3 (C-6'), 151.3 (C-8'a), 165.7 (C-1"); (HRMS: Found M+ 
495.2226, C26H32NOsF3 requires M, 495 .2231). 
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(1R,2"R)-2-(N-tert-Butylamino-1-(2,2-dimethyl-1 ,3-benzodioxin-6-yl)ethyl-(2-methoxy-2-
trifluoromethyl)phenylacetate, 33 and its (1S,2"R)-diastereomer, 34 
Reaction of (rac)-16 under the conditions described above resulted in an inseparable mixture of 
diastereomers. These were purified as above and analysed by 1HNMR. 
33 34 Multiplicity Assignment 
cS (ppm) J(Hz) cS (ppm) J(Hz) 
1.06 0.98 s t-Bu 
1.53 1.52 s 2x2'-CH3 
2.83 12.3 and 4.1 2.75 12.3 and 3.9 dd 2-HA 
3.00 12.3 and 9.5 2.99 12.3 and 9.3 dd 2-Hs 
3.54 3.43 s 2"-0CH3 
4.72 15.2 4.78 15.0 d 4'-HA 
4.79 15.2 4.84 15.0 d 4'-Hs 
5.87 9.5 and 4.1 5.92 9.3 and 3.9 dd 1-H 
6.75 8.6 6.79 8.4 d 8'-H 
6.83 2.2 6.99 2.1 d 5'-H 
7.07 8.6 and 2.2 7.18 8.4 and 2.1 dd 7'-H 
7.2-7.5 7.2-7.5 m other Ar-H 




N 0 r 2" ,..-Nd .. CH3 H 1·· 
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s- -..-:::: 2'" 
I 
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A solution of triphosgene (220 mg, 0. 7 mmol) in dichloromethane ( 4 cm3) was stirred at room 
temperature under nitrogen while a solution of (R)-phenylethylamine (0.26 cm3, 247 mg, 2.0 
mmol) and N,N-diisopropylethylamine (0.40 cm3, 296 mg, 2.3 mmol) in dichloromethane (3.5 
cm3) was added over 45 min. The resulting solution was stirred for a further 10 min followed by 
the addition of a solution of (rac)-16 (558 mg, 2.0 mmol) in dichloromethane (4 cm3). After 10 
min stirring the solution was evaporated to dryness under reduced pressure and the residue taken 
up in ethyl acetate (1 00 cm3), washed with equal volumes of 10% NaHC03 and brine and dried 
(MgS04). The solvent was removed under reduced pressure to produce 768 mg crude material 
(largely comprising two major products and starting material). The material was adsorbed onto 
silica and chromatographed using a mixture of ethyl acetate and petroleum ether (1 0/90 followed 
by 20/80) as eluent. Only the more polar of the products could be isolated cleanly to give 36 
(156 mg, 0.4 mmol, 37% as a single diastereomer), mp 149-150°C (ethyl acetate/hexane); [a]0 -
3.5° (c 1.1 methanol); Found C, 70.1; H, 8.6; N, 6.7; C25H34N20 4 requires C, 70.4; H, 8.0; N, 
6.6%; Vmax (CHCh)/cm·1 1652 (C=O urea); DH (400MHz, CDCh) 1.40 (9H, s, t-Bu), 1.47 (3H, d, 
J 6.8 Hz, 2"-H), 1.54 (6H, s, 2x2'-CHJ), 3.23 (1H, dd, J 16.3 and 2.3 Hz, 2-HA), 3.44 (1H, dd, J 
16.3 and 9.6 Hz, 2-Hs), 4.76 (1H, dd, J 9.6 and 2.3 Hz, 1-H), 4.82 (2H, s, 4'-H2), 4.94 (1H, m, 
1 "-H), 6.60 (1H, d, J 7.4 Hz, 1 "-NH), 6.80 (1H, d, J 8.4 Hz, 8'-H), 6.93 (IH, d, J 1.9 Hz, 5'-H), 
7.09 (lH, dd, J 8.4 and 1.9 Hz, 7'-H), 7.2-7.4 (5H, m, 2"'-6'"-H); 8c (lOOMHz, CDCh) 23 .3 (C-
2"), 24.7 and 24.8 (2'-CHJ) 29.1 (t-Bu -CH3), 49.9 (C-1 "), 54.4 (C-2), 55.9 (t-Bu -C(CH3)3), 60.9 
(C-4'), 76.7 (C-1), 99.7 (C-2'), 117.3 (C-8'), 119.7 (C-4'a), 121.9 (C-5'), 125.5 (C-7'), 126.0, 
126.7 and 128.5 (C-2"'-C-6"'), 134.1 (C-6'), 145.3 (C-1"'), 151.1 (C-8'a), 160.7 (C=O); (HRMS: 





Triphosgene (2.96 g, 10 mmol) was dissolved in dichloromethane (50 cm3) and stirred at room 
temperature and under nitrogen. A solution of (R)-phenylethylamine (3 cm3, 3.15 g, 26 mmol) 
and N,N-diisopropylethylamine (5 cm3, 3.71 g, 29 mmol) in dichloromethane (80 cm3) was 
added over 2 h via a dropping funnel. The mixture was then cooled to 0 °C and added to a 
mixture of 0.5M HCl (100 cm3) and ice (100 cm3) and the organic layer removed. This acid 
wash step was repeated and the combined aqueous phases were extracted with dichloromethane 
(50 cm3). The combined organic phases were washed with a brine/ice mixture and concentrated 
by rotary evaporation to afford a yellow oil (3.05g, 77%). The product was purified by 
Kugelrohr distillation to give a colourless oil [a]o +12° (undiluted, lit. +13°); Vmax (CHCh)/cm-1 
2250 (N=C=O). 
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(1R,1 "R)-2- [N-tert-Butyl-N-(1-phenethylamido )amino ]-1-(2,2-dimethyl-1,3-benzodioxin-6-
yl)ethanol37 
To a stirred solution of (R)-16 (140 mg, 0.5 mmol) in dichloromethane (2.5 cm3) at room 
temperature and under nitrogen was added 35 (0.10 cm3, 0.105 g, 0.7 mmol). The mixture was 
stirred overnight and then adsorbed onto silica gel. Elution with ethyl acetate/petroleum ether 
(20/80) yielded 37 (186 mg, 0.4 mmol, 87%), mp 122-125°C (ethyl acetate/hexane); [a]0 -58.0° 
(c 1.0 methanol); Found C, 70.3; H, 8.4; N, 6.6; C2sH34N204 requires C, 70.4; H, 8.0; N, 6.6%; 
Vmax (CHCh)/cm-1 1640 (C=O urea); 8H (400MHz, CDCh) 1.41 (9H, s, t-Bu), 1.45 (3H, d, J 6.8 
Hz, 2"-H), 1.54 (6H, s, 2x2'-CHJ), 1.67 (1H, br s, OH), 3.27 (1H, dd, J 16.0 and 2.2 Hz, 2-HA), 
3.49 (1H, dd, J 16.0 and 9.5 Hz, 2-Hs), 4.75 (1H, dd, J9.5 and 2.2 Hz, 1-H), 4.84 (2H, s, 4'-H2), 
4.92 (1H, m, 1 "-H), 6.46 (1H, d, J 7.7 Hz, 1 "-NH), 6.81 (1H, d, J 8.4 Hz, 8'-H), 6.98 (IH, d, J 
2.2 Hz, 5'-H), 7.12 (1H, dd, J 8.4 and 2.2 Hz, 7'-H), 7.2-7.4 (5H, m, 2"'-6"'-H); 8c (100MHz, 
CDCh) 23.3 (C-2"), 24.6 and 24.8 (2'-CHJ) 29.3 (t-Bu -CI-1]), 50.0 (C-1 "), 54.4 (C-2), 55.8 (t-Bu 
-C(CH3)3), 60.9 (C-4'), 77.2 (C-1), 99.7 (C-2'), 117.3 (C-8'), 119.6 (C-4'a), 121.9 (C-5'), 125.5 
(C-7'), 125.9, 126.7 and 128.4 (C-2"'-C-6"'), 134.2 (C-6'), 145.1 (C-1"'), 151.1 (C-8'a), 160.7 
(C=O); (HRMS: Found~. 426.2505, C2sH34N204 requires M, 426.2518). 
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5.3 Analyses 
5.3.1 X-ray Powder Diffraction Patterns 
These were measured on a Philips PW 1050/80 goniometer with Ni-filtered CuK.a radiation (A.= 
1.5418A). The powder patterns were collected in the range 6° ~ 28 ~ 40° with step scans of 28 
= 0.1 °. Samples were coground to ensure particle sizes were less than 100 J.LID and carefully 
packed into a 20 x 14 x 1 mm aluminium holder so as to minimise preferred orientation effects. 
5.3.2 NMR Determination of optical purity of (R)-Albuterol Acetonide, (R)-16 
Typically, 16 (5 mg) and (R)- or (S)-0-Acetylmandelic acid (6 mg) were dissolved in CDCh (1 
cm3) and the 1H-NMR spectra recorded (400MHz). Several of the protons in 16 gave well 
distinguished peaks for each diastereomer formed in solution and integration of these pairs 
(usually the t-Bu peaks) allowed determination of the optical purity. 
Data for the 400 MHz 1H-NMR spectrum obtained with (R)-0-Acetylmandelic Acid: 
MAJOR [(R)-16] MINOR [(S)-16] Multiplicity Assignment 
8 (ppm) J(Hz) 8 (ppm) J(Hz) 
1.22 1.18 s t-Bu 
1.53 1.53 s 2x2'-CH3 
2.81 12.2 and 10.2 obscured dd 2-HA 
2.87 12.2 and 2.6 2.95 12.2 and 3.0 dd 2-Hs 
4.80 4.80 s 4'-H2 
4.89 10.2 and 2.6 4.96 3.0 and 10.2 dd 1-H 
6.74 8.4 6.75 8.2 d 8'-H 
6.94 2.0 7.00 1.7 d 5'-H 
7.04 8.4 and 2.0 7.09 8.2 and 1.7 dd 7'-H 
(R)-OAM: 8H 2.13, 5.83, 7.30, 7.47 ppm 
5.3.3 Chiral High Performance Liquid Chromatography on (R)-16 and (R)-24 









Phenomenex Chirex 3022 
hexane/ 1 ,2-dichloroethane/methanol/trifl uoroacetic acid 
(240/140/7 .5/1) 
ambient 
1 0 3 . -1 . cm.mm 
254nm 
hexane/1 ,2-dichloroethane/methanol (240/140/7 .5) 
Linearity and limit of quantitation 
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A set of standard solutions of (rac)-16 was prepared by dissolving 11.0 mg in 10 cm3 sample 
solvent and making the appropriate dilutions to give solutions of 1.1 00, 0.440, 0.088 and 0.044 
mg.cm-3• Triplicate injections of each solution were made and a linear curve constructed. The 
limit of quantitation was taken as the lowest concentration at which reproducible integration of 
peak areas of the impurity (S)-16 could be achieved and was determined to be 0.044 mg.cm-3 of 
the racemic solution which relates to 0.022 mg.cm-3 of the single enantiomer. 
Sample analysis 
About 10 mg sample was accurately weighed into a vial and I cm3 sample solvent added. The 
solutions were injected in duplicate and the enantiomeric excess in each determined by: 
% ee = I oo(_A_re_a--,:-( R--:=-)_-_A_re_a --':-( S--':-) J 
Area ( R) + Area ( S) 









Phenomenex Chirex 3022 
hexane/1 ,2-dichloroethane/methanol/trifluoroacetic acid 
(240/140/20/1) 
ambient 
1 2 3 ° -1 . cm.mm 
280nm 
25 j.1l 
hexane/1 ,2-dichloroethane/methanol (240/140/7 .5) 
Linearity and limit of quantitation 
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231 mg (rae )-albuterol was dissolved in a minimum of methanol and diluted to 10 cm3 with the 
sample solvent used in the ketal determinations. Suitable dilutions with this solvent produced 
samples of 1.155, 0.462, 0.046 and 0.023 mg.cm-3 which gave a satisfactory calibration curve. 
The limit of quantitation under these conditions was determined to be 0.023 mg.cm-3 of the 
racemate which gives 0.012 mg.cm-3 in each enantiomer. 
Sample analysis 
5mg sample was accurately weighed, diluted to 1 cm3 and analysed as for 16 
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5.4 Crystal Structure Determinations 
5.4.1 (rac)-Albuterol Acetonide, (rac)-16 
Preliminary X-Ray photography 
Oscillation and Weissenberg photographs were taken using a non-integrating Stoe goniometer. A 
Stoe Reciprocal Lattice Explorer was used to record de Jong-Bouman, Buerger precession and 
cone-axis photographs. The crystals were irradiated with Ni-filtered CuK.a radiation (A= 1.5418 
A) generated by Philips PW1120 and PW1140 X-ray generators. Space group data and 
preliminary cell parameters were determined from the photographs. 
Intensity data collection 
The data collection was performed at 293K on a Nonius KappaCCD usmg graphite 
monochromated 1kW Mo radiation (A= 0.7107 A). 474 exposures of 40s each were collected. 
400 of these were in the x = 0° position with 0.5° rotation in$ per image. The remaining 74 
exposures were collected with x = -90° and 0.5° rotation in ro per image. Data processing was 
performed by DENZO-SMN. 118 
Both default and modified approaches with the program SHELX-8675 were applied in attempts 
to elucidate the structure using direct methods. These were not successful. 
5.4.2 (R)-Albuterol Acetonide, (R)-16 
Preliminary X-Ray photography 
Space group data and preliminary cell parameters were determined from oscillation and 
Weissenberg photographs taken using the instrumentation and conditions described in Section 
5.4.1. 
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Intensity data collections 
Two intensity data collections were performed on an Enraf-Nonius CAD4 diffractometer using 
graphite-monochromated MoKa. radiation (A.= 0.7107 A) at 298 K and 223 K respectively. The 
unit cell was refmed by least-squares analysis of the setting angles of 24 reflections collected in 
the 8 range 16-17°. Data in the range 1 o ~ 8 ~ 25° (298 K) and 1 o ~ 8 ~ 30° (223 K) were 
collected in the ro-28 scan mode with a final acceptance limit of20cr at 20°min-1 and a maximum 
scan time of 40s per reflection. The vertical aperture length was fixed at 4 mm, the aperture 
width varied according to (1.12+1.05 tan 8) mm and the scan width as ro=(0.80+0.35 tan 8)0 • In 
both cases, Friedel opposite reflections were collected. Intensity control was performed every 
hour by means of three reference reflections. Lorentz-polarisation corrections were applied to 
the data in addition to empirical absorption corrections. 119 
Structure analysis and refinement 
Using the data collected at 298 K, all non-hydrogen atoms were found by direct methods using 
SHELX-8675. The structures were refined by full-matrix least-squares on F2 using SHELXL-
93120. Friedel opposites were not merged since it was intended to distinguish the absolute 
structure of the compound. All non-hydrogen atoms were treated anisotropically. Hydrogen 
atoms were located in difference electron density syntheses, placed in geometrically calculated 
positions and linked to a common temperature factor for chemically equivalent entities. In the 
final cycle of refinement, the Flack parameter91 was inspected but this failed to indicate the 
correctness of the handedness assigned to the structure. The refined parameters from the 298K 
data set were used as input for further refinement using the low temperature (223 K) intensity 
data. Inspection of the Flack parameter generated here led to the conclusion that the atoms 
present in the molecule (C, H, N, 0) were insufficiently large to produce a significant difference 
between Friedel opposite reflections. 
The residual indices based on F values (R1) and F
2 (R2) quoted in Table 3.1 are defined as: 
where w is the weighting scheme: w = 1 I [cr2(F0
2
) + (aP)2 + bP] 
P = [max(O,F/) + 2F/] I 3 
(a and b refined for structure) 
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5.4.3 (R)-Phenylethylurea of (S)-Albuterol Acetonide, 36 
Preliminary X-Ray photography 
Oscillation, Weissenberg, de Jong-Bouman and precession photographs were taken as described 
for (rac)-16 (Section 5.4.1). 
Intensity data collection 
The data collection was performed at 293K on a Nonius KappaCCD usmg graphite 
monochromated 1kW Mo radiation(/..= 0.7107 A). 237 exposures of 40s each were collected. 
200 of these were in the x = 0° position with 1° rotation in ~ per image. The remaining 3 7 
exposures were collected with x = -90° and 1° rotation in ro per image. Data processing was 
performed by DENZO-SMN. 118 
Structure analysis and refinement 
As before, all non-hydrogen atoms were found by direct methods using SHELX-8675, and the 
structure was refmed by full-matrix least-squares on F2 using SHELXL-93 120. Non-hydrogen 
atoms were again treated anisotropically and location and treatment of hydrogen atoms was as 
for the previous structure. An extinction correction was applied in the final refinement step. 
The defmition of the residual indices quoted in Table 3.4 is given in Section 5.4.2 on page 76. 
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APPENDIX 1 CRYSTAL STRUCTURE DATA FOR (+)-16 
Table A1 : Atomic coordinates and equivalent isotropic displacement parameters, U(eq) (A2 x 
10\ with e.s.d. ' s in parentheses. U(eq) is defmed as one third of the trace of the 
orthogonalised Uij tensor. 
Atom X/ a Y/b Z/c U(eq) 
C1 -0.0704(5) 0.0946(3) 0.9105(1) 29(1) 
C2 0.0668(5) 0.0063(3) 0.8840(1) 30(1) 
C3 -0.0004(5) -0.0399(3) 0.8419(1) 31(1) 
C4 -0.2092(5) 0.0066(3) 0.8269(1) 33(1) 
C5 -0.3487(5) 0.0971(4) 0.8528(1) 40(1) 
C6 -0.2794(5) 0.1384(3) 0.8941(1) 38(1) 
C7 -0.0101(5) 0.1353(3) 0.9574(1) 29(1) 
07 0.2250(3) 0.1317(2) 0.9654(1) 34(1) 
C8 -0.1208(2) 0.0202(2) 0.9881(1) 33(1) 
N9 -0.0810(2) 0.0632(2) 1.0343(1) 29(1) 
C10 -0.1466(2) -0.0545(2) 1.0675(1) 33(1) 
C11 -0.3994(2) -0.0769(2) 1.0667(1) 49(1) 
C12 -0.0746(8) 0.0089(4) 1.1117(1) 55(1) 
C13 -0.0276(7) -0.2078(4) 1.0598(1) 53(1) 
C14 0.1427(5) -0.1391 ( 4) 0.8133(1) 43(1) 
015 0.0605(4) -0.1417(3) 0.7694(1) 45(1) 
C16 -0.1741(6) -0.1621(4) 0.7660(1) 42(1) 
017 -0.2864(4) -0.0334(3) 0.7859(1) 43(1) 
C18 -0.2561(8) -0.3078(4) 0.7873(2) 62(1) 
C19 -0.2295(8) -0.1530(5) 0.7179(1) 66(2) 
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Table A2: Anisotropic displacement parameters (A2 x 10\ with e.s.d.'s in parentheses. The 
anisotropic displacement factor exponent takes the form: 
-2n2[h2a* 2U 11 + ...... +2hka*b*U12] 
Atom u(ll) u(22) u(33) u(23) u{l2) u{l3) 
C1 32(1) 29(1) 25(1) -1(1) 0(1) 1(1) 
C2 28(1) 35(1) 28(1) 0(1) -1(1) 4(1) 
C3 31(1) 33(1) 30(1) -2(1) -1(1) 2(1) 
C4 36(2) 31(1) 31(1) -2(1) -6(1) 3(1) 
C5 34(1) 43(2) 44(2) -7(1) -12(1) 13(1) 
C6 34(1) 40(2) 39(2) -8(1) -2(1) 13(1) 
C7 30(1) 29(1) 26(1) -2(1) 3(1) -1(1) 
07 31(1) 36(1) 34(1) -3(1) -2(1) -4(1) 
C8 39(2) 32(1) 29(1) -2(1) 0(1) -7(1) 
N9 30(1) 29(1) 27(1) 1(1) 2(1) -5(1) 
C10 35(1) 31(1) 32(1) 4(1) 4(1) -6(1) 
C11 34(2) 54(2) 57(2) 11(2) 8(2) -9(2) 
C12 79(3) 55(2) 30(2) 11 (1) -4(2) -22(2) 
C13 52(2) 40(2) 66(2) 14(2) 10(2) 2(2) 
C14 39(2) 56(2) 34(2) -14(1) -2(1) 11(2) 
015 44(1) 65(1) 28(1) -12(1) 4(1) -3(1) 
C16 42(1) 49(2) 36(2) -13(1) -4(1) 1(1) 
017 48(1) 45(1) 36(1) -8(1) -13(1) 8(1) 
C18 57(2) 43(2) 84(3) -13(2) 7(2) -7(2) 
C19 70(3) 86(3) 40(2) -17(2) -13(2) 0(3) 
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Table A3: Bond Lengths (A) with e.s.d.'s in parentheses. 
Bond Length Bond Length 
C1- C2 1.382(4) C8 -N9 1.475(2) 
C1- C6 1.395(4) N9- C10 1.493(2) 
C1- C7 1.517(4) C10- Cll 1.519(2) 
C2 -C3 1.403(4) C10- C12 1.520(4) 
C3 -C4 1.387(4) C10- C13 1.531(4) 
C3- C14 1.495(4) C14- 015 1.425(4) 
C4- C5 1.392(4) 015- C16 1.413(4) 
C4- 017 1.375(4) C16- 017 1.440(4) 
C5- C6 1.373(5) C16- C18 1.507(5) 
C7- 07 1.422(3) C16- C19 1.506(5) 
C7 -C8 1.522(3) 
Table A4: Bond Angles (degrees) with e.s.d. 'sin parentheses. 
Bonds Angle Bonds Angle 
C6- C1- C7 119.1(2) C8- N9- C10 115.4(1) 
C2- C1- C7 122.7(2) N9- C10- C13 112.1(2) 
C2- C1- C6 118.1(3) N9- C10- C12 106.1(2) 
C1- C2- C3 121.7(2) N9- C10- Cll 109.8(1) 
C2- C3- C14 122.5(3) C12- C10- C13 108.7(2) 
C2- C3- C4 118.4(3) C11- C10- C13 11 0.2(2) 
C4- C3- C14 119.2(3) C11 - C10- C12 109.9(2) 
C3- C4- 017 121.8(3) C3- C14- 015 111.2(2) 
C3- C4- C5 120.9(3) C14- 015- C16 114.3(2) 
CS- C4- 017 117.4(3) 015- C16- C19 1 06.4(3) 
C4- C5- C6 119.3(3) 015- C16- C18 113.2(3) 
C1- C6- C5 121.7(3) 015- C16- 017 109.3(3) 
C1- C7- C8 108.8(2) C18- C16- C19 113 .2(3) 
C1- C7- 07 112.9(2) 017-C16-C19 105.6(3) 
07- C7- C8 107.9(2) 017- C16- C18 1 08.9(3) 
C7- C8- N9 110.4(1) C4- 017- C16 115.2(2) 
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Table AS: Torsion Angles (degrees) with e.s.d.'s in parentheses. 
Bonds Angle Bonds Angle 
C6 - C 1 - C7 - 07 -160.2(2) C3 - C4 - C5 - C6 -1.1(5) 
C2 - C 1 - C7 - 07 24.5(4) C5 - C4 - 0 1 7 - C 16 -161.6(3) 
C6- C1 - C7- C8 80.0(3) 0 1 7 - C4 - C5 - C6 179.3(3) 
C2 - C 1 - C7 - C8 -95.3(3) C4- C5- C6- C1 1.3(5) 
C7 - C 1 - C6 - C5 -176.1(3) C 1 - C7 - C8 - N9 -175.5(2) 
C2 - C 1 - C6 - C5 -0.6(4) 07 - C7 - C8 - N9 61.7(2) 
C6 - C 1 - C2 - C3 -0.5(4) C7 - C8 - N9 - C 1 0 -169.8(1) 
C7 - C 1 - C2 - C3 174.9(3) C8- N9- C10- Cll -65.6(1) 
C 1 - C2 - C3 - C4 0.7(4) C8- N9- C10- C12 175.7(2) 
C 1 - C2 - C3 - C 14 -178.2(3) C8-N9-C10-C13 57.2(2) 
C2 - C3 - C 14 - 015 -167.3(3) C3 - C 14 - 0 15 - C 16 -45.4(4) 
C2 - C3 - C4 - C5 . 0.1(4) C14- 015- C16- 017 63.5(3) 
C2 - C3 - C4 - 017 179.7(3) C14- 015- C16- C18 -58.1(4) 
C4 - C3 - C 14 - 015 13.9(4) C14- 015- C16- C19 177.0(3) 
C 14 - C3 - C4 - 0 1 7 -1.4(4) 0 15 - C 16 - 0 1 7 - C4 -48.1(3) 
C 14 - C3 - C4 - C5 179.0(3) C 18 - C 16 - 0 1 7 - C4 76.0(3) 
C3 - C4 - 0 1 7 - C 16 18.8(4) C 19 - C 16 - 0 1 7 - C4 -162.2(3) 
Table A6: Hydrogen atom coordinates and isotropic displacement parameters, Uiso (A2 x 
10\ with e.s.d. 'sin parentheses. 
Atom X/ a Y/b ZJc Uiso 
H2 0.2071(5) -0.0232(3) 0.8944(1) 50(6) 
H5 -0.4874(5) 0.1293(4) 0.8422(1) 50(6) 
H6 -0.3742(5) 0.1971(3) 0.9116(1) 50(6) 
H7 -0.0670(5) 0.2382(3) 0.9641(1) 25(7) 
H7A 0.2753(12) 0.2192(5) 0.9645(13) 54(11) 
H8A -0.2810(2) 0.0171(2) 0.9825(1) 52(5) 
H8B -0.0602(2) -0.0814(2) 0.9827(1) 52(5) 
H9A 0.0693(2) 0.0802(2) 1.0360(1) 36(8) 
HllA -0.4399(2) -0.1574(2) 1.0867(1) 77(4) 
HllB -0.4462(2) -0.1042(2) 1.0376(1) 77(4) 
HllC -0.4721(2) 0.0166(2) 1.0754(1) 77(4) 
H12A -0.1148(44) -0.0625(16) 1.1344(1) 77(4) 
H12B -0 .1484(3 7) 0.1051(17) 1.1169(4) 77(4) 
H12C 0.0851(10) 0.0240(31) 1.1119(3) 77(4) 
H13A -0.0532( 41) -0.2742(13) 1.0845(5) 77(4) 
H13B 0.1306(9) -0.1905(5) 1.0565(10) 77(4) 
H13C -0.0856(35) -0.2550(16) 1.0337(6) 77(4) 
H14A 0.2954(5) -0.1007(4) 0.8135(1) 52(5) 
H14B 0.1445(5) -0.2427(4) 0.8250(1) 52(5) 
H18A -0.2421(46) -0.2991(14) 0.8186(2) 77(4) 
H18B -0.1677(32) -0.3927(6) 0.7772(7) 77(4) 
H18C -0.4106(16) -0.3242(18) 0.7798(8) 77(4) 
H19A -0.3894(8) -0.1480(31) 0.7142(1) 77(4) 
H19B -0.1725( 40) -0.2423(16) 0.7032(2) 77(4) 
Hl9C -0.1620(38) -0.0628(18) 0.7055(2) 77(4) 
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APPENDIX 2 CRYSTAL STRUCTURE DATA FOR 36 
Table B 1: Atomic coordinates and equivalent isotropic displacement parameters, U(eq) (A 2 x 
10\ with e.s.d.'s in parentheses. U(eq) is defined as one third of the trace of the 
orthogonalised Uij tensor. 
Atom X! a Y/b Z/c U(eq) 
C1 0.3313(2) 0.6232(1) 0.8981(1) 41(1) 
C2 0.4470(2) 0.6644(1) 0.8597(1) 44(1) 
C3 0.5513(2) 0.7503(1) 0.8684(1) 44(1) 
C4 0.5340(2) 0.7953(1) 0.9164(1) 43(1) 
C5 0.4195(2) 0.7544(1) 0.9555(1) 47(1) 
C6 0.3215(2) 0.6687(1) 0.9465(1) 46(1) 
C7 0.2199(2) 0.5297(1) 0.8889(1) 42(1) 
07 0.2421(1) 0.4950(1) 0.8372(1) 50(1) 
C8 -0.0023(2) 0.5422(1) 0.8994(1) 41(1) 
N9 -0.1201(2) 0.4533(1) 0.8976(1) 40(1) 
C10 -0.1661(2) 0.4027(1) 0.9480(1) 48(1) 
C11 -0.3353(3) 0.4522(2) 0.9759(1) 91(1) 
C12 -0.2103(4) 0.2975(2) 0.9378(1) 92(1) 
C13 0.0155(3) 0.4064(2) 0.9834(1) 72(1) 
C14 0.6813(3) 0.7948(1) 0.8273(1) 53(1) 
015 0.7215(2) 0.8931(1) 0.8396(1) 52(1) 
C16 0.7820(2) 0.9083(1) 0.8917(1) 49(1) 
017 0.6238(2) 0.8818(1) 0.9269(1) 51(1) 
C18 0.9636(3) 0.8513(2) 0.9067(1) 68(1) 
C19 0.8067(4) 1.0153(1) 0.8980(1) 74(1) 
C20 -0.2420(2) 0.4405(1) 0.8551(1) 40(1) 
020 -0.4085(1) 0.4037(1) 0.8576(1) 51(1) 
N21 -0.1667(2) 0.4714(1) 0.8094(1) 57(1) 
C22 -0.2758(2) 0.4710(1) 0.7607(1) 49(1) 
C23 -0.2122(3) 0.3872(1) 0.7262(1) 68(1) 
C24 -0.2554(2) 0.5656(1) 0.7323(1) 51(1) 
C25 -0.4207(3) 0.6076(2) 0.7100(1) 76(1) 
C26 -0.4044(5) 0.6929(2) 0.6825(1) 102(1 ) 
C27 -0.2231(5) 0.7357(2) 0.6753(1) 98(1) 
C28 -0.0595(4) 0.6952(2) 0.6977(1) 87(1) 
C29 -0.0747(3) 0.6103(1) 0.7261(1) 67(1) 
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Table B2: Anisotropic displacement parameters (A2 x 10\ with e.s.d. 'sin parentheses. The 
anisotropic displacement factor exponent takes the form: 
-2n2[h2a*2UIJ + ...... +2hka*b*Ul2] 
Atom u(ll) u(22) u(33) u (23) u(J2) u(l3) 
C1 344(1) 46(1) 42(1) -1(1) -4(1) -1(1) 
C2 44(1) 50(1) 38(1) -7(1) 1(1) -4(1) 
C3 43(1) 50(1) 37(1) -1(1) 2(1) -4(1) 
C4 42(1) 46(1) 40(1) -3(1) -2(1) -5(1) 
C5 47(1) 58(1) 35(1) -5(1) 2(1) -7(1) 
C6 43(1) 56(1) 40(1) 0(1) 2(1) -9(1) 
C7 34(1) 46(1) 45(1) -3(1) -3(1) -2(1) 
07 39(1) 58(1) 54(1) -16(1) 1(1) -1(1) 
C8 35(1) 42(1) 46(1) -1(1) -2(1) -1(1) 
N9 38(1) 44(1) 39(1) 3(1) -3(1) -4(1) 
C10 45(1) 57(1) 42(1) 10(1) 0(1) -3(1) 
Cll 66(1) 153(2) 54(1) 18(1) 15(1) 28(1) 
C12 137(2) 66(1) 72(1) 25(1) -13(1) -32(1) 
C13 65(1) 93(1) 58(1) 29(1) -16(1) -6(1) 
C14 60(1) 56(1) 42(1) -2(1) 7(1) -12(1) 
015 64(1) 53(1) 40(1) 5(1) -3(1) -11 (1) 
C16 55(1) 54(1) 40(1) 3(1) 0(1) -12(1) 
017 58(1) 51(1) 44(1) -6(1) 5(1) -13(1) 
C18 53(1) 96(1) 56(1) 7(1) -4(1) -3(1) 
C19 100(2) 63(1) 59(1) 1(1) 2(1) -29(1) 
C20 33(1) 44(1) 43(1) -1(1) -1(1) 2(1) 
020 36(1) 63(1) 53(1) 2(1) -3(1) -9(1) 
N21 33(1) 97(1) 42(1) 8(1) -5(1) -9(1) 
C22 38(1) 71 (1) 38(1) 2(1) -3(1) -3(1) 
C23 79(1) 62(1) 62(1) -3(1) -5(1) 0(1) 
C24 54(1) 59(1) 40(1) -5(1) -4(1) 5(1) 
C25 69(1) 87(1) 72(1) 7(1) -15(1) 12(1) 
C26 124(2) 84(2) 96(2) 24(1) -19(2) 33(1) 
C27 147(3) 57(1) 89(2) 12(1) 2(2) 5(1) 
C28 109(2) 71(1) 82(2) -2(1) 1 0(1) -24(1) 
C29 62(1) 71(1) 67(1) 3(1) 0(1) -9(1) 
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Table B3: Bond Lengths (A) with e.s.d.'s in parentheses. 
Bond Length Bond Length 
C1- C2 1.379(2) C14- 015 1.425(2) 
C1- C6 1.394(2) 015- C16 1.412(2) 
C1- C7 1.517(2) C16- 017 1.445(2) 
C2- C3 1.401(2) C16- C18 1.507(3) 
C3 -C4 1.384(2) C16- C19 1.502(3) 
C3- C14 1.503(2) C20- 020 1.236(2) 
C4-C5 1.387(2) C20- N21 1.345(2) 
C4- 017 1.371(2) N21- C22 1.450(2) 
C5- C6 1.378(2) C22- C23 1.521 (2) 
C7 -07 1.418(2) C22- C24 1.506(2) 
C7- C8 1.533(2) C24- C25 1.382(3) 
C8-N9 1.468(2) C24- C29 1.377(3) 
N9- C10 1.500(2) C25- C26 1.380(4) 
N9- C20 1.378(2) C26- C27 1.373(5) 
C10-CII I .513(3) C27- C28 1.365(4) 
C10- C12 1.512(3) C28- C29 1.388(3) 
C10- C13 1.526(3) 
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Table B4: Bond Angles (degrees) with e.s.d.'s in parentheses. 
Bonds Angle Bonds Angle 
C6- C1- C7 120.1(1) C3 - C14- 015 110.3(1) 
C2- C1- C7 121.6(1) C14- 015- C16 114.0(1) 
C2- C1- C6 118.3(1) 015- C16- C19 106.3(1) 
C1- C2- C3 121.6(1) 015- C16- C18 113.4(1) 
C2- C3- C14 122.1(1) 015- C16- 017 109.8(1) 
C2- C3- C4 118.7(1) C18- C16- C19 113.6(2) 
C4- C3- C14 119.2(1) 017- C16- C19 105.4(1) 
C3- C4- 017 122.1(1) 017- C16- C18 108.0(1) 
C3- C4- C5 120.4(1) C4- 017- C16 115.2(1) 
C5- C4- 017 117.5(1) N9 - C20- N21 115.0(1) 
C4- C5- C6 119.9(1) N9 - C20- 020 123.6(1) 
C1- C6- C5 121.1(1) 020- C20- N21 121.4(1) 
C1- C7- C8 111.1(1) C20- N21- C22 123.8(1) 
C1- C7- 07 112.5(1) N21- C22- C24 111.5(1) 
07- C7- C8 107.8(1) N21 - C22- C23 111.1(1) 
C7- C8- N9 115.4(1) C23 - C22 - C24 111.0(1) 
C8- N9- C20 117.1(1) C22 - C24 - C29 121.9(2) 
C8- N9- ClO 118.6(1) C22 - C24 - C25 119.6(2) 
C10- N9- C20 119.8(1) C25 - C24 - C29 118.6(2) 
N9- C10- Cl3 109.2(1) C24 - C25 - C26 120.5(2) 
N9- C10- C12 110.1(1) C25- C26- C27 120.7(3) 
N9- C10- C11 110.6(1) C26- C27- C28 119.1(3) 
C12- C10- Cl3 107.1(2) C27 - C28 - C29 120.7(2) 
C11-C10-Cl3 108.0(2) C24 - C29 - C28 120.5(2) 
C11 - C10- C12 111.7(2) 
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Table B5: Torsion Angles (degrees) with e.s.d.'s in parentheses. 
Bonds Angle Bonds Angle 
C6 - C 1 - C7 - 07 178.4(1) C8- N9- C10- C13 -39.6(2) 
C2 - C 1 - C7 - 07 -2.9(2) C 10 - N9 - C20 - 020 13.6(2) 
C6 - C 1 - C7 - C8 57.4(2) C10- N9- C20- N21 -166.4(1) 
C2 - C 1 - C7 - C8 -123.9(1) C20 - N9 - C 1 0 - C 13 165.0(1) 
C7-C1-C6-C5 -179.2(1) C20 - N9 - C 1 0 - C 12 47.7(2) 
C2 - C 1 - C6 - C5 2.1(2) C20 - N9 -C 10 - C 11 -76.3(2) 
C6 - C 1 - C2 - C3 -0.7(2) C3 - C 14 - 015 - C 16 47.9(2) 
C7 - C 1 - C2 - C3 -179.4(1) C14- 015- C16- 017 -63.5(2) 
C 1 - C2 - C3 - C4 -1.1(2) C14- 015- C16- C18 57.4(2) 
C 1 - C2 - C3 - C 14 178.7(1) C14- 015- C16- C19 -177.1(1) 
C2 - C3 - C 14 - 0 15 162.8(1) 015 - C 16 - 0 1 7 - C4 46.2(2) 
C2 - C3 - C4 - C5 . 1.6(2) C 18 - C 16 - 0 1 7 - C4 -77.9(2) 
C2 - C3 - C4 - 017 -176.8(1) C 19 - C 16 - 0 1 7 - C4 160.4(1) 
C4 - C3 - C 14 - 0 15 -17.4(2) N9 - C20 - N21 - C22 -175.5(1) 
C 14 - C3 - C4 - 0 1 7 3.4(2) 020- C20- N21 - C22 4.5(2) 
C 14 - C3 - C4 - C5 -178.2(1) C20- N21- C22- C23 -1 02.5(2) 
C3 - C4 - 0 1 7 - C 16 -17.9(2) C20- N21 - C22- C24 133.1(1) 
C3 - C4 - C5 - C6 -0.3(2) N21- C22- C24- C25 -136.1(2) 
C5 - C4 - 0 1 7 - C 16 163.6(1) N21- C22- C24- C29 46.2(2) 
0 1 7 - C4 - C5 - C6 178.2(1) C23 - C22 - C24 - C25 99.4(2) 
C4-C5-C6-C1 -1.6(2) C23- C22- C24- C29 -78.3(2) 
C 1 - C7 - C8 - N9 -173.1(1) C22 - C24 - C29 - C28 177.1(2) 
07 - C7 - C8 - N9 63.3(2) C22 - C24 - C25 - C26 -178.1(2) 
C7 - C8 - N9 - C 1 0 96.9(1) C25 - C24 - C29 - C28 -0.6(3) 
C7 - C8 - N9 - C20 -107.0(1) C29 - C24 - C25 - C26 -0.3(3) 
C8 - N9 - C20 - 020 -142.2(1) C24 - C25 - C26 - C27 2.2(4) 
C8 - N9 - C20 - N21 37.8(2) C25- C26- C27- C28 -3.0(4) 
C8-N9-C10-C11 79.2(2) C26- C27- C28- C29 2.0(4) 
C8- N9- C10- C12 -156.9(1) C27 - C28 - C29 - C24 -0.2(4) 
Table B6: Hydrogen atom coordinates and isotropic displacement parameters, Uiso (A2 x 
10\ with e.s.d. ' s in parentheses. 
Atom X/ a Ylb Z/c Uiso 
H2 0.4561(2) 0.6344(1) 0.8274(1) 71(2) 
H5 0.4089(2) 0.7847(1) 0.9878(1) 71(2) 
H6 0.2476(2) 0.6409(1) 0.9732(1) 71(2) 
H7 0.2716(2) 0.4808(1) 0.9129(1) 71(2) 
H7A 0.3456(15) 0.4644(13) 0.8348(2) 71(2) 
H8A -0.0185(2) 0.5714(1) 0.9335(1) 71(2) 
H8B -0.0554(2) 0.5870(1) 0.8739(1) 71(2) 
HilA -0.3411 (15) 0.4298(9) 1.0114(2) 97(2) 
HllB -0.4577(4) 0.4374(9) 0.9586(4) 97(2) 
HllC -0.3144(12) 0.5207(2) 0.9756(5) 97(2) 
H12A -0.3357(12) 0.2918(2) 0.9203(6) 97(2) 
H12B -0.2153(24) 0.2633(3) 0.9703(1) 97(2) 
H12C -0.1081(14) 0.2705(3) 0.9162(5) 97(2) 
H13A -0.0134(8) 0.3740(1 0) 1.0156(3) 97(2) 
Hl3B 0.0492(14) 0.4725(2) 0.9903(5) 97(2) 
Hl3C 0.1248(7) 0.3751(10) 0.9664(3) 97(2) 
Hl4A 0.8049(3) 0.7592(1) 0.8250(1) 71(2) 
H14B 0.6160(3) 0.7910(1) 0.7936(1) 71(2) 
H18A 1.0061(14) 0.8702(8) 0.9410(3) 97(2) 
H18B 1.0677(8) 0.8638(9) 0.8821(4) 97(2) 
H18C 0.9326(7) 0.7837(2) 0.9066(6) 97(2) 
Hl9A 0.8450(24) 1.0295(2) 0.9333(2) 97(2) 
H19B 0.6836(8) 1.0470(2) 0.8903(6) 97(2) 
H19C 0.9072(18) 1.0380(2) 0.8745(5) 97(2) 
H21 -0.0469(2) 0.4927(1) 0.8091(1) 71(2) 
H22 -0.4163(2) 0.4621(1) 0.7690(1) 71(2) 
H23A -0.2816(17) 0.3904(6) 0.6936(2) 97(2) 
H23B -0.2427(20) 0.3274(1) 0.7433(3) 97(2) 
H23C -0.0721(5) 0.3909(6) 0.7200(5) 97(2) 
H25 -0.5439(3) 0.5783(2) 0.7136(1) 71(2) 
H26 -0.5174(5) 0.7216(2) 0.6687(1) 71(2) 
H27 -0.2118(5) 0.7916(2) 0.6554(1) 71(2) 
H28 0.0633(4) 0.7249(2) 0.6940(1) 71(2) 
H29 0.0379(3) 0.5834(1) 0.7411(1) 71(2) 
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APPENDIX 3 (diskette) STRUCTURE FACTOR DATA FOR (+)-16 and 36 
The attached diskette contains text files listing the observed and calculated structure factors with 
standard deviations for observed structure factors for both of the structures solved. 
Compound 
(+)-16 
36 
Filename 
16sfac.txt 
36sfac.txt 
